
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500005A6611D60D31.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="frontendo" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC9520000/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520000/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Frontiers in Endocrinology" /><meta name="citation_title" content="Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness" /><meta name="citation_author" content="Raghuveer Kavarthapu" /><meta name="citation_author" content="Maria L. Dufau" /><meta name="citation_publication_date" content="2022" /><meta name="citation_volume" content="13" /><meta name="citation_doi" content="10.3389/fendo.2022.949396" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC9520000/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC9520000/" /><meta name="citation_pmid" content="36187116" /><meta name="DC.Title" content="Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Frontiers Media SA" /><meta name="DC.Contributor" content="Raghuveer Kavarthapu" /><meta name="DC.Contributor" content="Maria L. Dufau" /><meta name="DC.Date" content="2022" /><meta name="DC.Identifier" content="10.3389/fendo.2022.949396" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness" /><meta property="og:type" content="article" /><meta property="og:description" content="The prolactin receptor (PRLR) is a member of the lactogen/cytokine receptor family, which mediates multiple actions of prolactin (PRL). PRL is a major hormone in the proliferation/differentiation of breast epithelium that is essential for lactation. It ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520000/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9520000/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Endocrinol%20(Lausanne)%22[journal]" class="navlink">Front Endocrinol (Lausanne)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9520000
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9520000/pdf/fendo-13-949396.pdf" class="int-view">PDF (1.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9520000/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9520000/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9520000" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="6SnIDP8P2pvVL79iobxd4RuD5u5rYHGSXZxJFfIgVqXtfA966NZjhoOM5VeQuNMC">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F&amp;text=Prolactin%20receptor%20gene%20transcriptional%20control%2C%20regulatory%20modalities%20relevant%20to%20breast%20cancer%20resistance%20and%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520000/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36187116/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36187116/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9520000/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Endocrinol%20(Lausanne)%22[journal]" class="navlink">Front Endocrinol (Lausanne)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9520000
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-frontendo.gif" alt="Logo of frontendo" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.frontiersin.org/endocrinology" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Front Endocrinol (Lausanne).</span> 2022; 13: 949396. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2022 Sep 15. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3389%2Ffendo.2022.949396" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3389/fendo.2022.949396</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC9520000</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36187116">36187116</a></div></div></div><h1 class="content-title">Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kavarthapu%20R%5BAuthor%5D">Raghuveer Kavarthapu</a> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dufau%20ML%5BAuthor%5D">Maria L. Dufau</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
*
</sup></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140651096417808_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140651096417808_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140651096417808_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140651096417808_ai" style="display:none"><div class="fm-affl" id="aff1">
Section on Molecular Endocrinology, Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States
</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="fn-a.j.b.f.a">Edited by: Vincent GOFFIN, INSERM U1151 Institut Necker Enfants Malades, France</div><div id="fn-a.j.b.f.b">Reviewed by: Linda Schuler, University of Wisconsin-Madison, United States; Ameae M Walker, University of California, Riverside, United States</div><div id="fn001">*Correspondence: Maria L. Dufau, <a href="mailto:dev@null" data-email="vog.hin.liam@muafud" class="oemail">vog.hin.liam@muafud</a>
</div><div id="fn002">This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology</div></div><div class="fm-article-notes hide half_rhythm" id="idm140651096417808_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 May 20; Accepted 2022 Aug 19.</div></div><div class="permissions half_rhythm hide" id="idm140651096417808_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2022 Kavarthapu and Dufau</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.j.b.m" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.j.b.mtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The prolactin receptor (PRLR) is a member of the lactogen/cytokine receptor family, which mediates multiple actions of prolactin (PRL). PRL is a major hormone in the proliferation/differentiation of breast epithelium that is essential for lactation. It is also involved in breast cancer development, tumor growth and chemoresistance. Human PRLR expression is controlled at the transcriptional level by multiple promoters. Each promoter directs transcription/expression of a specific non-coding exon 1, a common non-coding exon 2 and coding exons E3-11. The identification of exon 11 of PRLR led to finding of alternative spliced products and two novel short forms (SF) that can inhibit the long form (LF) of PRLR activity with relevance in physiological regulation and breast cancer. Homo and heterodimers of LF and SF are formed in the absence of PRL that acts as a conformational modifier. Heterodimerization of SF with LF is a major mechanism through which SF inhibits some signaling pathways originating at the LF. Biochemical/molecular modeling approaches demonstrated that the human PRLR conformation stabilized by extracellular intramolecular S&#x02212;S bonds and several amino acids in the extracellular D1 domain of PRLR SF are required for its inhibitory actions on PRLR LF-mediated functions. Studies in breast cancer cells demonstrated that the transcription of PRLR was directed by the preferentially utilized PIII promoter, which lacks an estrogen responsive element. Complex formation of non-DNA bound ER&#x003b1; dimer with Sp1 and C/EBP&#x003b2; dimers bound to their sites at the PRLR promoter is required for basal activity. Estradiol induces transcriptional activation/expression of the PRLR gene, and subsequent studies revealed the essential role of autocrine PRL released by breast cancer cells and CDK7 in estradiol-induced PRLR promoter activation and upregulation. Other studies revealed stimulation of the PRLR promoter activity and PRLR LF protein by PRL in the absence of estrogen <em>via</em> the STAT5/phospho-ER&#x003b1; activation loop. Additionally, EGF/ERBB1 can induce the transcription of PRLR independent of estrogen and prolactin. The various regulatory modalities contributing to the upregulation of PRLR provide options for the development of therapeutic approaches to mitigate its participation in breast cancer progression and resistance.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">prolactin receptor (PRLR), transcriptional regulation, gene structure, signal transduction, breast cancer, prolactin (PRL)</span></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">Prolactin (PRL) is a multifaceted protein hormone produced and secreted by the anterior pituitary gland, and it is also found in extra-pituitary tissues, including the mammary gland, brain, decidua, gonads, pancreas, immune cells, liver and adipose tissue, where it exerts autocrine and paracrine functions [reviewed in (<a href="#B1" rid="B1" class=" bibr popnode">1</a>&#x02013;<a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. Prolactin directs several physiological functions, such as lactation, immunomodulatory actions, and glucose and lipid metabolism, and is involved in pathological modalities, such as prolactinoma, hypogonadism and several cancers [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>&#x02013;<a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. The highly diversified actions of PRL are mediated through its transmembrane prolactin receptor (PRLR), a member of the lactogen/cytokine receptor family, which is expressed ubiquitously and functions as a dimer activated by PRL. A short isoform of PRLR with 310 amino acids (aa) was initially cloned from rat liver (<a href="#B5" rid="B5" class=" bibr popnode">5</a>). The long form (LF) of PRLR with 610 aa was isolated from human hepatoma and breast cancer cells (<a href="#B6" rid="B6" class=" bibr popnode">6</a>) and from the rat ovary (<a href="#B7" rid="B7" class=" bibr popnode">7</a>). The monomeric structure of human PRLR (hPRLR) was resolved using combined NMR and computational approaches (<a href="#B8" rid="B8" class=" bibr popnode">8</a>). PRLR gene expression is controlled by multiple promoters that regulate sustained PRLR levels and function (<a href="#B9" rid="B9" class=" bibr popnode">9</a>). In humans, there are several PRLR isoforms, including the LF, many short forms (SFs), an intermediate variant and a soluble isoform [ (<a href="#B10" rid="B10" class=" bibr popnode">10</a>), reviewed in (<a href="#B11" rid="B11" class=" bibr popnode">11</a>)]. The expression of these isoforms of PRLR widely varies in different tissues and is required for specific functions of the organ system at specific times. Certain short isoforms of hPRLR can interfere with the essential signaling of the long isoform, thereby exerting inhibitory action [reviewed in (<a href="#B11" rid="B11" class=" bibr popnode">11</a>, <a href="#B12" rid="B12" class=" bibr popnode">12</a>)].</p><p class="p p-last">PRL is structurally similar to growth hormone and can act as a growth factor, immunomodulator, or neurotransmitter in an autocrine and paracrine manner [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>)]. PRL mediates its actions through PRLR, resulting in the activation of the janus tyrosine kinase (JAK)/signal transducer and activator of transcription (STAT) and mitogen-activated protein kinase (MAPK) signaling pathways [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>)]. PRL/PRLR has been implicated in the development of several cancers and tumor progression [reviewed in (<a href="#B13" rid="B13" class=" bibr popnode">13</a>&#x02013;<a href="#B20" rid="B20" class=" bibr popnode">20</a>)]. Hence, PRLR signaling has emerged as a relevant target in breast cancer. PRL is normally secreted in a pulsatile fashion, and this is clinically important for diagnostics related to problems in lactation and female infertility. Additionally, elevated circulating or locally produced PRL levels are associated with the risk of breast cancer [reviewed in (<a href="#B17" rid="B17" class=" bibr popnode">17</a>, <a href="#B18" rid="B18" class=" bibr popnode">18</a>)]. PRL, through its cognate receptor, stimulates various downstream signaling cascades involving STAT5, RAS and MAPK, and phosphatidylinositol 3-kinase (PI3K) have been implicated in mammary tumorigenesis [reviewed in (<a href="#B18" rid="B18" class=" bibr popnode">18</a>, <a href="#B19" rid="B19" class=" bibr popnode">19</a>, <a href="#B21" rid="B21" class=" bibr popnode">21</a>)]. The gain-of-function mutations in PRLR reported in benign and malignant breast cancer patients may support the hypothesis that PRLR signaling cascades could participate in benign breast tumorigenesis (<a href="#B22" rid="B22" class=" bibr popnode">22</a>). In this review, we provide an overview of the current understanding of the transcriptional regulation of PRLR and signal transduction in physiological and pathological modalities in mammary glands with special emphasis on the role of PRL/PRLR signaling in breast cancer.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">PRL and PRLR</h2><div id="s2_1" class="sec sec-first"><h3 id="s2_1title">PRL and PRLR distribution and biological functions</h3><p class="p p-first">Prolactin is a 23 kDa protein hormone containing 199 aa that is produced in the lactotroph cells of the anterior pituitary gland. Prolactin is also secreted in an extra-pituitary and autocrine/paracrine manner from different tissues, such as mammary glands, brain, decidua, gonads, pancreas, immune cells, liver, and fat [reviewed in (<a href="#B1" rid="B1" class=" bibr popnode">1</a>&#x02013;<a href="#B3" rid="B3" class=" bibr popnode">3</a>)]. The gene encoding human PRL is &#x0223c;10 kb with five exons, and four introns is present on chromosome 6. In addition to its normal expression in the anterior pituitary, it is also expressed in mammary epithelial cells, the decidua, brain, myometrium, endometrium, lacrimal gland, thymus, spleen, skin fibroblasts, sweat glands and immune system cells. PRL secretion is regulated by several factors. Ovarian steroids, specifically estrogens, modulate PRL synthesis and prolactin release while suppressing dopamine synthesis [reviewed in (<a href="#B1" rid="B1" class=" bibr popnode">1</a>&#x02013;<a href="#B3" rid="B3" class=" bibr popnode">3</a>)]. Increased PRL secretion (prolactinomas) directly suppresses the secretion of GnRH and indirectly suppresses follicle-stimulating hormone and luteinizing hormone, thereby disrupting the HPG axis and the ovulatory cycle (reviewed in 1-2). PRL performs innumerable physiological functions in the body, including mammary gland development, lactation, gonadal functions (luteal cycle, uterine actions, Leydig cell development), parental behavior, preadipocyte differentiation, osmoregulation, angiogenesis, immunomodulatory function, islet cell proliferation, adrenal steroidogenesis, bone and calcium homeostasis, anovulation, reduced stress responses, oxytocin secretion and lipid metabolism. Prolactin also promotes neurogenesis in maternal and fetal brains [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>, <a href="#B3" rid="B3" class=" bibr popnode">3</a>)].</p><p class="p p-last">PRLR has been identified in numerous cells and tissues of adult mammals. Cellular proliferation is also an important function of PRL in mammals. The expression of receptors (short and long forms) tends to vary with the stage of the estrous cycle, pregnancy, and lactation (<a href="#B23" rid="B23" class=" bibr popnode">23</a>). The expression of PRLR in the late gestational fetal rat using <em>in situ</em> hybridization and immunocytochemistry showed that the long and short isoforms of PRLR were expressed during late fetal development (days 17.5 to 20.5). These studies showed PRLR transcripts were widely expressed in tissues from all three germ layers, in addition to the classic target organs of PRL (<a href="#B24" rid="B24" class=" bibr popnode">24</a>). The expression of PRLR mRNA in the fetal adrenal cortex, gastrointestinal and bronchial mucosae, renal tubular epithelia, choroid plexus, thymus, liver, pancreas, and epidermis was higher than that in other tissues (<a href="#B23" rid="B23" class=" bibr popnode">23</a>).</p></div><div id="s2_2" class="sec"><h3 id="s2_2title">PRLR structure and isoforms</h3><p class="p p-first">PRLRs belong to the lactogen/cytokine receptor superfamily, which mediates the various cellular actions of PRL in different target tissues. PRL binds to preexisting PRLR dimers and acts as a conformational modifier, which results in the activation of the JAK/STAT pathway and MAPK and SRC kinases, thus leading to the induction of PRL responsive genes [reviewed in (<a href="#B4" rid="B4" class=" bibr popnode">4</a>, <a href="#B18" rid="B18" class=" bibr popnode">18</a>)].</p><div id="s2_2_1" class="sec"><p></p><h4 id="s2_2_1title" class="inline">PRLR structure </h4><p class="p p-first-last">PRLR has three main domains: extracellular, transmembrane and intracellular. The extracellular domain is divided into two fibronectin domains, D1 and D2, and the WS motif in D2 acts as a molecular switch during ligand-bound activation of PRLR (<a href="#B25" rid="B25" class=" bibr popnode">25</a>). PRLR has a single-pass transmembrane chain, and the receptor chain does not possess kinase activity. The receptor chain is dependent on the associated kinases to transduce phosphorylation-based signal cascades. The intracellular domain includes proline-rich sequence-mediated JAK2 association to the prolactin receptor is required but not sufficient for signal transduction Box-1/2 sub-domains. Box-1 is known to interact with JAK2 and SRC family kinases such as FYN [reviewed in (<a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. The intracellular domain of PRLR-LF is intrinsically highly unstructured/disordered and binds to negatively charged lipids of the inner plasma membrane through conserved motifs resembling immuno receptor tyrosine-based activation motifs. However, this lipid association of the PRLR intracellular domain is not accompanied by induced folding and is independent of specific tyrosine phosphorylation. These attributes may contribute to regulating intracellular signaling (<a href="#B26" rid="B26" class=" bibr popnode">26</a>). There are two short isoforms of hPRLR generated by alternative splicing to exon 11 (<a href="#B10" rid="B10" class=" bibr popnode">10</a>).</p></div><div id="s2_2_2" class="sec sec-last"><p></p><h4 id="s2_2_2title" class="inline">PRLR gene and isoforms </h4><p class="p p-first">The genomic organization of the hPRLR gene (&#x0003e;200 kb) is complex and subject to alternative splicing, which results in several isoforms of the receptor. The gene resides on chromosome 5p14-13. The hPRLR gene contains eleven exons, where exon 1 consists of six non-coding sequences (hE1<sub>3</sub>, hE1<sub>N1-5</sub>) that are alternatively spliced to a common non-coding exon 2, and only exons 3 to 11 are coding exons [ (<a href="#B9" rid="B9" class=" bibr popnode">9</a>); <a href="/pmc/articles/PMC9520000/figure/f1/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1" rid-ob="ob-f1" co-legend-rid="lgnd_f1"><span>
<strong>Figure&#x000a0;1</strong>
</span></a>]. The LF of hPRLR is encoded by exons 3-10 (<a href="/pmc/articles/PMC9520000/figure/f2/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2" rid-ob="ob-f2" co-legend-rid="lgnd_f2"><span>
<strong>Figure&#x000a0;2</strong>
</span></a>). Additionally, an intermediate form (412 aa) with partial deletion of 198 aa within the cytoplasmic domain in exon 10 of the LF was isolated from the rat Nb2 lymphoma cell line (<a href="#B28" rid="B28" class=" bibr popnode">28</a>) and human breast cancer cells (<a href="#B29" rid="B29" class=" bibr popnode">29</a>). In addition, a soluble PRLR lacking transmembrane and cytoplasmic regions was isolated from the rat ovary (<a href="#B7" rid="B7" class=" bibr popnode">7</a>). The transmembrane domain is encoded by Exon 8, while most of the intracellular domain is encoded by Exon 10 (<a href="/pmc/articles/PMC9520000/figure/f2/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2" rid-ob="ob-f2" co-legend-rid="lgnd_f2"><span>
<strong>Figure&#x000a0;2</strong>
</span></a>). Alternative splicing of exons 10 and 11 with a truncated intracellular domain resulted in two novel SFs of hPRLR, S1a and S1b, which inhibit the LF signal induced by PRL [ (<a href="#B10" rid="B10" class=" bibr popnode">10</a>); <a href="/pmc/articles/PMC9520000/figure/f2/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2" rid-ob="ob-f2" co-legend-rid="lgnd_f2"><span>
<strong>Figures&#x000a0;2</strong>
</span></a>, <a href="/pmc/articles/PMC9520000/figure/f3/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3" rid-ob="ob-f3" co-legend-rid="lgnd_f3"><span>
<strong>3</strong>
</span></a>]. In addition, a unique spliced variant designated S1c, which completely lacks exon 10, has been identified in human spermatozoa (<a href="#B30" rid="B30" class=" bibr popnode">30</a>). These short forms S1a and S1b are expressed as cell surface transmembrane receptors with a reduced cytoplasmic domain and unique C-termini S1b was far more effective in inhibiting the PRL-induced activation of the &#x003b2;-casein gene promoter mediated by LF (<a href="#B31" rid="B31" class=" bibr popnode">31</a>, <a href="#B32" rid="B32" class=" bibr popnode">32</a>). A subsequent study demonstrated a naturally occurring &#x00394;S2 deletion variant of SF in normal and cancerous human cells. These studies have also demonstrated that removal of the S2 extracellular subdomain can alter the conformation of the intracellular signaling region of the LF and both SFs (S1a and S1b), thereby supporting the concept that the conformation of the ECD can affect the conformation of the intracellular domain (<a href="#B33" rid="B33" class=" bibr popnode">33</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f1" co-legend-rid="lgnd_f1"><a href="/pmc/articles/PMC9520000/figure/f1/" target="figure" rid-figpopup="f1" rid-ob="ob-f1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651088332464"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g001.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651088332464"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f1"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f1/" target="figure" rid-figpopup="f1" rid-ob="ob-f1">Figure&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Schematic representation of multiple exons 1 (hE1<sub>3,</sub> hE1<sub>N1-5</sub>) driven by individual promoters and alternative splicing to common exon 2 of human PRLR. Exon 3 has initiation codon. PIII/hEI3 is the predominantly utilized generic promoter in addition to five specific exon 1/promoters (hE1N1 to hE1N5).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f2" co-legend-rid="lgnd_f2"><a href="/pmc/articles/PMC9520000/figure/f2/" target="figure" rid-figpopup="f2" rid-ob="ob-f2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651091236240"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g002.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651091236240"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f2"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f2/" target="figure" rid-figpopup="f2" rid-ob="ob-f2">Figure&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>Schematic representation of human PRLR isoforms generated by alternative splicing [adapted from reference (<a href="#B27" rid="B27" class=" bibr popnode">27</a>)] PRLR (prolactin receptor) Atlas Genet Cytogenet. ** indicates soluble form of PRLR.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f3" co-legend-rid="lgnd_f3"><a href="/pmc/articles/PMC9520000/figure/f3/" target="figure" rid-figpopup="f3" rid-ob="ob-f3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651091232592"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g003.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651091232592"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f3"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f3/" target="figure" rid-figpopup="f3" rid-ob="ob-f3">Figure&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>Structure of human PRLR variants. LF, long form; IF, intermediate form; S1a, S1b &#x00026; S1c, short forms; PRLBP, prolactin binding protein; LF&#x00394;S1, long form lacking D1 domain; LF&#x00394;S2, long form lacking D2 domain; &#x00394;, deleted exon. D1, D2, N-terminal subdomain; WS, WSXWS motif; C, cysteine; Y, tyrosine; EC, extracellular domain; TM, transmembrane domain; IC, intracellular domain [adapted from reference (<a href="#B27" rid="B27" class=" bibr popnode">27</a>)].</p></div></div></div><p class="p">Our studies on human LF, S1a and S1b have revealed the existence of constitutive LF and SF homodimers and heterodimers (LF/S1a or LF/S1b) under non-reducing conditions in the absence of PRL that acts as conformational modifier (<a href="#B31" rid="B31" class=" bibr popnode">31</a>). Both LF and SFs (S1a and S1b), as dimers, are capable of ligand binding and PRL-induced phosphorylation of JAK2, but only LF can activate downstream STAT5 signaling. S1a and S1b cannot induce the downstream activation of STAT5 due to the lack of an extended cytoplasmic domain. PRL signaling through the SF of PRLR in mouse ovaries actively regulates the expression of several genes and can profoundly affect follicular survival. SF can mediate the activation of MAPK and PI3K pathways [reviewed in (<a href="#B34" rid="B34" class=" bibr popnode">34</a>)]. In breast cancer, the ratio of SFs (S1a and S1b) to LF is markedly reduced compared to that in adjacent tissue, which indicates that the loss of inhibitory regulation of LF could increase tumor cell proliferation (<a href="#B35" rid="B35" class=" bibr popnode">35</a>). Two intramolecular disulfide bonds within the extracellular D1 domains are essential for the inhibitory function of S1b on LF. Additionally, the JAK2 association was disrupted. S&#x02212;S bond disruption of S1b (S1bx) affects the dimerization interface, thus causing a significant decrease in LF heterodimerization with S1bx and an increase in homodimerization of S1bx. Therefore, stability of the PRLR structure by intramolecular S&#x02212;S bonds is required for the inhibitory action of S1b on LF-mediated function (<a href="#B36" rid="B36" class=" bibr popnode">36</a>). Additionally, mutations in E69 of the D1 domain of S1b and neighboring amino acid residues (R66, E67, E42) close to its surface binding domain cause a loss of its inhibitory effect, while those away from this region or mutants in the D2 domain have no effect. These findings underscore the significant role of extracellular D1 on the S1b conformation and its inhibitory action in PRL-induced LF function [ (<a href="#B12" rid="B12" class=" bibr popnode">12</a>); <a href="/pmc/articles/PMC9520000/figure/f4/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4" rid-ob="ob-f4" co-legend-rid="lgnd_f4"><span>
<strong>Figure&#x000a0;4</strong>
</span></a>]. In addition, PRL signaling through SF of mouse PRLR can either stimulate or inhibit a substantial number of transcription factors in the decidua as well as ovary. Few transcription factors have been shown to be similarly regulated in both tissues, while most transcription factors are oppositely regulated by PRL (<a href="#B37" rid="B37" class=" bibr popnode">37</a>). Additional studies are needed to better understand the role of alternatively spliced PRLR isoforms and the manner in which such splicing is regulated in breast cancer.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f4" co-legend-rid="lgnd_f4"><a href="/pmc/articles/PMC9520000/figure/f4/" target="figure" rid-figpopup="f4" rid-ob="ob-f4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651090911120"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g004.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651090911120"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f4"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f4/" target="figure" rid-figpopup="f4" rid-ob="ob-f4">Figure&#x000a0;4</a></div><!--caption a7--><div class="caption"><p>Mechanism of inhibitory action of short form S1b PRLR on PRL-induced long-from (LF) receptor signaling (reproduced from reference <a href="#B12" rid="B12" class=" bibr popnode">12</a>). Homodimer of the hPRLR long form (LF) mediates PRL stimulated JAK2/Stat5 signaling required for transcription/expression PRL/PRLR target genes which are essential for the various biological effects of the hormone. The inhibitory action of short form S1b on LF&#x02019;s function induced by PRL results from LF/SF heterodimer formation and marked reduction of LF/LF homodimers which are required by Stat5 activation.</p></div></div></div></div></div><div id="s2_3" class="sec sec-last"><h3 id="s2_3title">Transcriptional regulation of PRLR</h3><p class="p p-first">The expression of PRLR is controlled by multiple promoters using a complex regulatory transcriptional network. In the rat these promoters are PI (gonad specific and SF1 dependent), PII (liver specific induced by HNF4), and PIII a widely expressed in all tissues and requires CCAAT/enhancer binding protein-&#x003b2; (C/EBP&#x003b2;) and specificity protein 1 (Sp1) for its activation. Promoter PI is inoperative in mice due to disruption of the SF1 motif. These multiple promoters have been shown to direct tissue-specific expression in the ovary, liver and mammary gland in rats [ (<a href="#B38" rid="B38" class=" bibr popnode">38</a>), reviewed in (<a href="#B39" rid="B39" class=" bibr popnode">39</a>)]. In humans, hPIII is a universal/generic promoter similar in structure and regulation to one of those found in rodents (PIII). This promoter in humans directs transcription in all PRL-responsive tissues as well as other promoter(s) of less known function (<a href="#B9" rid="B9" class=" bibr popnode">9</a>). The promoters include the predominantly utilized generic promoter 1/exon 1 (PIII/hEI3), which is also present in rats and mice, and five human-specific exon 1/promoters (hE1<sub>N1</sub> to hE1<sub>N5</sub>) [ (<a href="#B9" rid="B9" class=" bibr popnode">9</a>, <a href="#B39" rid="B39" class=" bibr popnode">39</a>); <a href="/pmc/articles/PMC9520000/figure/f1/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1" rid-ob="ob-f1" co-legend-rid="lgnd_f1"><span>
<strong>Figure&#x000a0;1</strong>
</span></a>]. The PRLR promoters belong to the TATA-less/initiator class and are activated by estradiol 17&#x003b2; (E2). The preferentially utilized human promoter III (hPIII) promoter contains Sp1 and C/EBP elements that bind to Sp1/Sp3 and C/EBP&#x003b2;, which are required for basal transcriptional activity (<a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>). These promoters were found to be utilized in breast cancer tissue and cell lines, including MCF7 and T47D, and variably used in other tissues (<a href="#B40" rid="B40" class=" bibr popnode">40</a>). Among these promoters, the generic hPIII (the human counterpart of rodent PIII), which drives the universal human E1<sub>3</sub> exon (the human counterpart of EIII in rodents), was functionally characterized in breast cancer cells, while the specific human exon hE<sub>N1</sub> directed by promoter hP<sub>N1</sub> is driven by domains containing an ETS element and a nuclear receptor NR half-site. The promoters for the specific human exons, i.e., hE<sub>N2-5</sub>, remain to be identified (<a href="#B39" rid="B39" class=" bibr popnode">39</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f5" co-legend-rid="lgnd_f5"><a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" rid-figpopup="f5" rid-ob="ob-f5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651094387840"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g005.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g005.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g005.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651094387840"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f5"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f5/" target="figure" rid-figpopup="f5" rid-ob="ob-f5">Figure&#x000a0;5</a></div><!--caption a7--><div class="caption"><p>Transcriptional regulation of hPRLR induced by E2. E2 induces ligand mediated ER&#x003b1;-Sp1-C/EBP&#x003b2; complex formation and binding to the hPIII promoter of the hPRLR gene (<a href="#B38" rid="B38" class=" bibr popnode">38</a>, <a href="#B39" rid="B39" class=" bibr popnode">39</a>). This results in increased transcription of PRLR. PRL/PRLR activates JAK/STAT that can induce the transcription of ER&#x003b1;. P4 (progesterone)/Prog receptor can induce transcription of PRLR through association with Sp1and C/EBP&#x003b2; through promoter hPIII.</p></div></div></div><p class="p p-last">E2 can induce an increase in hPRLR mRNA transcripts directed by the hPIII promoter <em>via</em> a non-classical ERE independent mechanism in breast cancer cells [ (<a href="#B40" rid="B40" class=" bibr popnode">40</a>); <a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>]. The association of ER&#x003b1; with DNA-bound Sp1 and C/EBP&#x003b2; is essential for E2-induced hPRLR gene transcription (<a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>). The additional interaction between zinc fingers of Sp1 and leucine zipper of C/EBP&#x003b2; stabilizes the ER&#x003b1;-Sp1-C/EBP&#x003b2; complex. The enhanced complex formation of the ER&#x003b1; dimer (DNA binding domain) with Sp1 (zinc finger motifs) and C/EBP&#x003b2; (basic region and leucine zipper) by E2 plays an essential role in the transcriptional activation of the PRLR gene [ (<a href="#B40" rid="B40" class=" bibr popnode">40</a>, <a href="#B41" rid="B41" class=" bibr popnode">41</a>); <a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>]. An autocrine/paracrine loop increases PRLR mRNA expression <em>via</em> its ligand PRL in breast cancer cells. Similarly, in MCF7 cells overexpressing PRL, upregulation of PRLR was observed in response to endogenous PRL but not exogenous PRL. Furthermore, there was an increase in ER levels and estrogen responsiveness in these MCF-7 cells. Owing to the positive effect of estrogen on PRLR transcription, this reciprocal regulation amplifies both ER and PRLR signaling in breast cancer (<a href="#B42" rid="B42" class=" bibr popnode">42</a>). Another steroid hormone that can also regulate PRLR transcription is progesterone through its receptor (<a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>). Progesterone participates in the menstrual cycle, pregnancy, and embryogenesis and can be involved in tumorigenesis as well as in normal growth. It has been reported that the progesterone receptor lacks the consensus sequence or half-sequence response element in the PRLR gene PIII promoter and demonstrated that progesterone induces an increase in PRLR mRNA in a non-classical manner by inducing the expression of PRLR through the cooperative activation of Sp1 and CEBP&#x003b2; at the PIII promoter in mouse cells and T47D breast cancer cells (<a href="#B43" rid="B43" class=" bibr popnode">43</a>).</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">PRLR Signal Transduction</h2><div id="s3_1" class="sec sec-first"><h3 id="s3_1title">JAK-STAT pathway</h3><p class="p p-first">This is the most classical and well-studied downstream signaling pathway induced by the binding of PRL to PRLR. This pathway appears to mediate most of the PRL actions in lobuloalveolar development and lactation (<a href="/pmc/articles/PMC9520000/figure/f6/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6" rid-ob="ob-f6" co-legend-rid="lgnd_f6"><span>
<strong>Figure&#x000a0;6</strong>
</span></a>). The intracellular domain of PRLR is devoid of any intrinsic enzymatic activity; however, ligand-mediated activation of PRLR results in tyrosine phosphorylation of numerous cellular proteins, including the receptor itself [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>, <a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. Binding of PRL to PRLR results in conformational induction of preformed dimers and activation of JAK2 by transphosphorylation, which brings two JAK2 molecules close to each other [reviewed in (<a href="#B2" rid="B2" class=" bibr popnode">2</a>, <a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. JAK2 kinases are involved in the phosphorylation of Tyr residues of the PRLR itself, and the phosphotyrosines serve as potential docking sites for transducer molecules containing SH2 domains [ (<a href="#B45" rid="B45" class=" bibr popnode">45</a>), reviewed (<a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. The phosphorylation of Tyr residues of PRLR occurs in all isoforms except short isoforms of PRLR [reviewed in (<a href="#B4" rid="B4" class=" bibr popnode">4</a>)]. The LF of PRLR mediates several processes upon receptor activation due to the phosphorylation of several Tyr residues present in PRLR (<a href="#B45" rid="B45" class=" bibr popnode">45</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f6" co-legend-rid="lgnd_f6"><a href="/pmc/articles/PMC9520000/figure/f6/" target="figure" rid-figpopup="f6" rid-ob="ob-f6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651092914560"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9520000_fendo-13-949396-g006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140651092914560"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f6"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f6/" target="figure" rid-figpopup="f6" rid-ob="ob-f6">Figure&#x000a0;6</a></div><!--caption a7--><div class="caption"><p>PRL/PRLR signaling pathways. PRL through its receptor PRLR induces multiple signaling cascades which include participation of JAK, SFK, PI3K/AKT, NEK3/VAV2, TEK/VAV1 kinases and STAT transcription factors. These signaling pathways are involved in lactation, immune response, cytoskeleton remodeling and cell growth, proliferation &#x00026; survival [adapted from reference (<a href="#B44" rid="B44" class=" bibr popnode">44</a>)].</p></div></div></div><p class="p p-last">The STAT family of proteins are the major transducers of cytokine receptor signaling, which contains eight members. STAT1/3 and STAT5a/5b have been identified as transducer molecules of PRLR. STAT contains five conserved domains: DNA-binding, SH3-like, SH2-like, and NH<sub>2</sub>- and COOH-terminal transactivating domains [ (<a href="#B46" rid="B46" class=" bibr popnode">46</a>), reviewed in 4)]. As per the consensus model of STAT activation, a phosphorylated Tyr of the activated receptor interacts with the SH2 domain of STAT. Then, STAT is phosphorylated by receptor-associated JAK kinase. The phosphorylated STAT dissociates from the receptor and undergoes homodimerization or heterodimerization through an interaction involving the phosphotyrosine of each monomer and the SH2 domain of another phosphorylated STAT molecule. The STAT dimer translocates to the nucleus and activates a STAT DNA-binding motif in the promoter of target genes such as &#x003b2;-casein, IRF1, c-Myc, and cyclin-D (<a href="#B46" rid="B46" class=" bibr popnode">46</a>). The consensus DNA motif (TTCxxxGAA), termed GAS (&#x003b3;-interferon activated sequence), is recognized by STAT1, STAT3, and STAT5 homo or heterodimers [reviewed in (<a href="#B47" rid="B47" class=" bibr popnode">47</a>, <a href="#B48" rid="B48" class=" bibr popnode">48</a>)].</p></div><div id="s3_2" class="sec"><h3 id="s3_2title">RAS/RAF/MAP kinase pathway</h3><p class="p p-first-last">In addition to JAK/STAT signaling initiated by the activation of PRLR, several reports implicate PRLR in the activation of the mitogen-activated protein (MAP) kinase cascade (<a href="#B49" rid="B49" class=" bibr popnode">49</a>, <a href="#B50" rid="B50" class=" bibr popnode">50</a>). Phosphotyrosine residues of PRLR can serve as docking sites for adapter proteins (Shc/Grb2/SOS) connecting the receptor to the RAS/RAF/MAPK cascade [ (<a href="#B49" rid="B49" class=" bibr popnode">49</a>, <a href="#B50" rid="B50" class=" bibr popnode">50</a>); <a href="/pmc/articles/PMC9520000/figure/f6/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6" rid-ob="ob-f6" co-legend-rid="lgnd_f6"><span>
<strong>Figure&#x000a0;6</strong>
</span></a>]. Although the JAK/STAT and MAPK pathways were initially regarded as independent or parallel pathways, results suggest that these pathways are interconnected [reviewed in (<a href="#B51" rid="B51" class=" bibr popnode">51</a>)].</p></div><div id="s3_3" class="sec sec-last"><h3 id="s3_3title">Other kinases: c-SRC and FYN</h3><p class="p p-first-last">Several reports indicate PRL-induced activation of members of the Src kinase family, c-SRC (reviewed in 4) and FYN (<a href="#B52" rid="B52" class=" bibr popnode">52</a>). PRL-induced rapid Tyr phosphorylation of insulin receptor substrate-1 (IRS-1) and a subunit of PI3K have been described. Both IRS-1 and PI3K seem to be associated with the PRLR complex. PRL-induced activation of PI3K has been proposed to be mediated by FYN (<a href="#B52" rid="B52" class=" bibr popnode">52</a>). PRL/PRLR can also induce TEC-VAV1 and NEK3-VAV-1/VAV-2 signaling cascades and function in the regulation of the cytoskeleton (<a href="/pmc/articles/PMC9520000/figure/f6/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6" rid-ob="ob-f6" co-legend-rid="lgnd_f6"><span>
<strong>Figure&#x000a0;6</strong>
</span></a>). NEK3 kinase has been shown to regulates PRL-mediated cytoskeletal reorganization and motility of breast cancer cells (<a href="#B53" rid="B53" class=" bibr popnode">53</a>, <a href="#B54" rid="B54" class=" bibr popnode">54</a>).</p></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Role of PRL/PRLR signaling in breast cancer</h2><div id="s4_1" class="sec sec-first"><h3 id="s4_1title">PRL/PRLR induced signaling cascades promote breast development and progression</h3><p class="p p-first-last">PRL plays a crucial role in mammary gland development and in the etiology and progression of breast cancer. Considerable supporting data indicate that PRL/PRLR hyper signaling contributes to the initiation of breast cancer. A strong correlation between breast cancer with increased PRL and PRLR has been reported in several studies (<a href="#B17" rid="B17" class=" bibr popnode">17</a>, <a href="#B55" rid="B55" class=" bibr popnode">55</a>&#x02013;<a href="#B58" rid="B58" class=" bibr popnode">58</a>). Higher levels of PRL in postmenopausal women may eventually lead to an increased risk of breast tumors and metastatic cancer (<a href="#B58" rid="B58" class=" bibr popnode">58</a>&#x02013;<a href="#B60" rid="B60" class=" bibr popnode">60</a>). In premenopausal women with breast cancer, there are higher-than-average levels of serum PRL together with elevated PRLR expression. These are associated with an increased risk of tumor progression and invasion (<a href="#B60" rid="B60" class=" bibr popnode">60</a>&#x02013;<a href="#B62" rid="B62" class=" bibr popnode">62</a>). An association is observed between invasive breast cancer risk in postmenopausal women with high circulating PRL, particularly for ER-positive disease. PRL/PRLR is expressed in 95% of mammary tumors and 60% of male breast carcinomas (<a href="#B63" rid="B63" class=" bibr popnode">63</a>). These findings were replicated in transgenic mice overexpressing PRL that develop mammary tumors and in <em>in vitro</em> studies where PRL played a role in the proliferation of breast cancer cells (<a href="#B64" rid="B64" class=" bibr popnode">64</a>, <a href="#B65" rid="B65" class=" bibr popnode">65</a>). A direct correlation is observed between single nucleotide polymorphisms (SNPs) in the <em>PRLR</em> gene and benign breast tumor incidence. The two SNPs PRLR-I76V and I146L demonstrate constitutive receptor activity, and one of the SNPs (PRLRI146L) correlates with benign breast disease in a patient cohort, but these patients did not have high levels of serum PRL (<a href="#B22" rid="B22" class=" bibr popnode">22</a>, <a href="#B66" rid="B66" class=" bibr popnode">66</a>). However, in subsequent study these SNPs in the PRLR gene were found not to be associated with breast cancer and multiple fibroadenoma (<a href="#B67" rid="B67" class=" bibr popnode">67</a>). In another study, SNPs were found in <em>PRL</em>, and <em>PRLR</em> genes were associated with breast cancer metastasis in Taiwanese women (<a href="#B68" rid="B68" class=" bibr popnode">68</a>). Studies from our lab and others in T47D and MCF-7 breast cancer cells have shown that the PI3K/AKT and RAF/MEK/ERK pathways are activated in parallel following PRL treatment, which leads to profound cell proliferation and survival (<a href="#B69" rid="B69" class=" bibr popnode">69</a>, <a href="#B70" rid="B70" class=" bibr popnode">70</a>). PRLR can also induce the MAPK/ERK signaling cascade <em>via</em> the PI3-kinase-dependent RAC/PAK/RAF/MEK pathway, which is in turn controlled by JAK2, SRC family kinases and focal adhesion kinase (FAK) (<a href="#B71" rid="B71" class=" bibr popnode">71</a>). In addition to the role of the predominant LF of PRLR in breast cancer, a recent study showed that the human intermediate PRLR (alternatively spliced isoform) is a mammary proto-oncogene capable of stimulating cell survival and proliferation (<a href="#B29" rid="B29" class=" bibr popnode">29</a>). Many breast tumors are characterized by reduced STAT5 and high levels of PRLR expression and MAPK signal components, including AP-1 and pro-invasive matrix metalloproteinases [reviewed in (<a href="#B56" rid="B56" class=" bibr popnode">56</a>)]. MMPs are highly invasive agents and are associated with resistance to chemotherapy and anti-estrogen treatments (<a href="#B72" rid="B72" class=" bibr popnode">72</a>). Extracellular matrix components in the breast tumor microenvironment can also influence PRL/PRLR signaling (<a href="#B73" rid="B73" class=" bibr popnode">73</a>, <a href="#B74" rid="B74" class=" bibr popnode">74</a>). In invasive breast cancer, there is a shift in PRL signaling from STAT5-mediated pathways to focal-adhesion kinase and MAPK pathways, thereby favoring proliferation (<a href="#B73" rid="B73" class=" bibr popnode">73</a>, <a href="#B74" rid="B74" class=" bibr popnode">74</a>). PRL signaling in high-density stiff collagen matrices increases MMP expression, thereby promoting cellular motility. Therefore, the tumor microenvironment may be responsible for favoring one signaling pathway over another (<a href="#B73" rid="B73" class=" bibr popnode">73</a>, <a href="#B74" rid="B74" class=" bibr popnode">74</a>). There is a complex interplay between PRLR and estrogen receptor (ER&#x003b1;), and there is an important role for the tumor microenvironment. The co-expression of PRLR and ER&#x003b1; in a non-compliant, rigid matrix is associated with increased tumor invasiveness and reduced responsiveness to estrogen antagonists (<a href="#B75" rid="B75" class=" bibr popnode">75</a>). PRLR signaling can also induce motility and invasion of T47D breast cancer cells by activating downstream effectors such as TEC and NEK3 kinases, thus leading to cytoskeletal and focal adhesion reorganization (<a href="#B54" rid="B54" class=" bibr popnode">54</a>, <a href="#B76" rid="B76" class=" bibr popnode">76</a>). Several studies using breast cancer cells have shown that PRL activates unliganded ER&#x003b1; through phosphorylation at the Ser118 and Ser167 residues. The activation of ER&#x003b1; promotes ligand-independent transcriptional initiation of ERE-dependent target genes, which seems to be an important factor in the proliferative and transcriptional actions of PRL in breast cancer cells (<a href="#B70" rid="B70" class=" bibr popnode">70</a>, <a href="#B77" rid="B77" class=" bibr popnode">77</a>, <a href="#B78" rid="B78" class=" bibr popnode">78</a>). The most significant transcription factor in PRL/PRLR signaling is STAT, which regulates the growth, differentiation, and survival of mammary tissue. STAT3 and STAT5 are activated/overexpressed in several types of cancers, including breast cancer [reviewed in (<a href="#B79" rid="B79" class=" bibr popnode">79</a>, <a href="#B80" rid="B80" class=" bibr popnode">80</a>)]. STAT5 can act as both a tumor suppressor and an oncogene in breast cancer under different circumstances. In ER-positive breast cancer, STAT5 expression enhanced the response to hormone therapy and increased the overall survival of patients [reviewed in (<a href="#B81" rid="B81" class=" bibr popnode">81</a>)]. Recent studies have shown that phosphorylation of STAT5a serine residues (S726 and S780) may regulate its activity to promote cell proliferation in MCF-7 cells (<a href="#B82" rid="B82" class=" bibr popnode">82</a>). Reports have indicated that STAT5 acts as a suppressor of breast cancer invasion and metastatic progression and can be used as a tumor marker of favorable prognosis [reviewed in (<a href="#B79" rid="B79" class=" bibr popnode">79</a>)]. STAT5 is progressively inactivated with the progression to metastatic breast cancer due to enhanced regulation by tyrosine phosphatases (<a href="#B83" rid="B83" class=" bibr popnode">83</a>). The activation of STAT5 in breast cancer cells promotes homotypic adhesion and inhibits the invasive characteristics of cells (<a href="#B84" rid="B84" class=" bibr popnode">84</a>).</p></div><div id="s4_2" class="sec"><h3 id="s4_2title">PRL and cyclin-dependent kinase 7 (CDK7) in estrogen-induced upregulation of PRLR in breast cancer cells</h3><p class="p p-first-last">We demonstrated the essential role of endogenous PRL in the upregulation of the PRLR promoter, which involves the requisite participation of E2/ER&#x003b1; at the hPIII promoter along with STAT5a (<a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>). Phosphorylated STAT5a, which associates with its functional element at hPIII, interacts with non-DNA-bound E2/ER&#x003b1;, which in turn associates in a complex with Sp1 and C/EBP&#x003b2; bound to their cognate DNA sites at the PRLR hPIII promoter [ (<a href="#B85" rid="B85" class=" bibr popnode">85</a>); <a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>]. We have shown in MCF-7 cells that E2 induces ER&#x003b1; phosphorylation at S118 <em>via</em> CDK7 kinase and greatly increases the recruitment of E2/ER&#x003b1; to the hPIII promoter over basal unliganded ER&#x003b1; (<a href="#B86" rid="B86" class=" bibr popnode">86</a>). Phosphorylation of ER&#x003b1; at S118 is necessary for its association with the Sp1-C/EBP&#x003b2; complex and its interaction with STAT5a. Inhibition by the specific CDK7 inhibitor THZ1 markedly reduced E2-induced ER&#x003b1; phosphorylation at S118, while the JAK2 inhibitor AG490 or MEK inhibitor U0219, which inhibits downstream JAK2-induced pathways known to phosphorylate unliganded ER&#x003b1; at S118 and S167, had no effect. Targeting CDK7 kinase, which is known to regulate both transcription and the cell cycle, and ER&#x003b1; phosphorylation with the THZ1 inhibitor was found to effectively inhibit the transcription of PRLR and cell migration in breast cancer cells (<a href="#B85" rid="B85" class=" bibr popnode">85</a>). Our studies may provide insights for therapeutic approaches that will mitigate the transcription/expression of PRLR and its participation in breast cancer progression fueled by E2 and PRL <em>via</em> their cognate receptors (<a href="/pmc/articles/PMC9520000/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>
<strong>Figure&#x000a0;5</strong>
</span></a>).</p></div><div id="s4_3" class="sec"><h3 id="s4_3title">Crosstalk between PRLR and other receptors in breast cancer</h3><p class="p p-first">Studies have indicated that PRLR signaling crosstalk with other receptors can influence signal transduction. PRLR interacts with integrin <em>via</em> the signal regulatory protein alpha transmembrane glycoprotein and SHP2 (<a href="#B87" rid="B87" class=" bibr popnode">87</a>). PRL/PRLR and E2/ER synergistically can regulate the gene expression and proliferation of breast cancer cells (<a href="#B87" rid="B87" class=" bibr popnode">87</a>). Furthermore, PRLR signaling tends to activate the unliganded ER (<a href="#B70" rid="B70" class=" bibr popnode">70</a>, <a href="#B77" rid="B77" class=" bibr popnode">77</a>). PRL and estrogen cooperatively induce phosphorylation of ERK1/2 and enhance prolonged activation of AP-1 in breast cancer cells (<a href="#B88" rid="B88" class=" bibr popnode">88</a>). This type of signaling pathway crosstalk can promote breast cancer progression and chemotherapeutic resistance. Crosstalk occurs between PRLR and EGFR/HER2 (<a href="/pmc/articles/PMC9520000/figure/f7/" target="figure" class="fig-table-link figpopup" rid-figpopup="f7" rid-ob="ob-f7" co-legend-rid="lgnd_f7"><span>
<strong>Figure&#x000a0;7</strong>
</span></a>). PRLR can activate HER2 signaling <em>via</em> JAK2 (<a href="#B70" rid="B70" class=" bibr popnode">70</a>, <a href="#B85" rid="B85" class=" bibr popnode">85</a>). We have demonstrated that PRL/PRLR induces HER2 phosphorylation at Tyr residues 1221 and 1222 through JAK2, thereby activating downstream PI3K/AKT pathways in both MCF-7 and T47D cells (<a href="#B70" rid="B70" class=" bibr popnode">70</a>). This crosstalk between PRLR and HER2 signaling further facilitates the phosphorylation of ER&#x003b1;, its recruitment to the PRLR promoter and upregulation of PRLR transcription. Interestingly, we also found that EGF/EGFR in MCF-7 and T47D cells can induce PRLR transcription <em>via</em> downstream MAPK and PI3K signaling pathways (<a href="/pmc/articles/PMC9520000/figure/f7/" target="figure" class="fig-table-link figpopup" rid-figpopup="f7" rid-ob="ob-f7" co-legend-rid="lgnd_f7"><span>
<strong>Figure&#x000a0;7</strong>
</span></a>). Crosstalk between the PRLR and progesterone receptor (PR) signaling pathways has been shown to be relevant to both breast development and progression. Both PR and STAT5a are key transcription factors in these pathways and have been shown to be mediators of breast cancer stem cell outgrowth (<a href="#B89" rid="B89" class=" bibr popnode">89</a>). This evidence, coupled with their established function in the same transcriptional complexes at phospho-PR-target genes with high cancer relevance, supports the importance of PR-PRLR crosstalk [reviewed in (<a href="#B90" rid="B90" class=" bibr popnode">90</a>)].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f7" co-legend-rid="lgnd_f7"><a href="/pmc/articles/PMC9520000/figure/f7/" target="figure" rid-figpopup="f7" rid-ob="ob-f7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140651085428144"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g007.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is fendo-13-949396-g007.jpg" src="/pmc/articles/PMC9520000/bin/fendo-13-949396-g007.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140651085428144"><a target="object" rel="noopener" href="/pmc/articles/PMC9520000/figure/f7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f7"><div><a class="figpopup" href="/pmc/articles/PMC9520000/figure/f7/" target="figure" rid-figpopup="f7" rid-ob="ob-f7">Figure&#x000a0;7</a></div><!--caption a7--><div class="caption"><p>PRLR and EGFR/HER2 signaling crosstalk in breast cancer. EGF released by stromal microenvironment surrounding the breast tumor activates signaling cascades that overlap with PRLR signaling cascades upon activation with PRL secreted by breast tumor cells. PRL stimulates HER2 and EGFR signaling pathways via JAK2. EGF/EGFR also activates STAT5 signaling indirectly via s-SRC. This crosstalk between receptors can increase progression of breast tumor and endocrine resistance [adapted from reference (<a href="#B44" rid="B44" class=" bibr popnode">44</a>)].</p></div></div></div></div><div id="s4_4" class="sec sec-last"><h3 id="s4_4title">Resistance to endocrine therapy in breast cancer and future perspectives</h3><p class="p p-first-last">Endocrine therapy is one of most effective forms of targeted adjuvant therapy for hormone receptor-positive breast cancer. Adjuvant therapy has been well established with different types of antiestrogens, including selective ER modulators (tamoxifen, raloxifene), which block the activity of ER, selective ER downregulators, such as fulvestrant, which causes destabilization and degradation of ER, and the third generation of aromatase inhibitors (anastrozole, letrozole and exemestane), which reduce the production of E2 in tumors [ (<a href="#B91" rid="B91" class=" bibr popnode">91</a>), reviewed in (<a href="#B92" rid="B92" class=" bibr popnode">92</a>)]. Although these endocrine therapies for women with ER+/PR+ breast cancer have led to substantial improvements, a significant number of cancer patients develop either intrinsic resistance or acquired resistance, which often results in tumor relapse. There can be multiple reasons for this endocrine resistance which includes mutations of ER, enhanced MAPK and PI3K/mTOR signaling pathways. Other aspects of endocrine resistance could result from overexpression of HER2, and crosstalk of ER with bypass signaling pathways, such as the EGFR/HER2 and PRLR signaling pathways [reviewed in (<a href="#B93" rid="B93" class=" bibr popnode">93</a>&#x02013;<a href="#B96" rid="B96" class=" bibr popnode">96</a>)]. To overcome HER2 hyperactivation, trastuzumab is still being used as the most effective form of treatment for ER+ and HER+ breast cancer patients. However, some cancer patients develop resistance to trastuzumab and tumor relapse within one year of treatment. Hyperactivation of HER2-induced downstream PI3K/AKT signaling is often observed in trastuzumab-resistant breast cancer patients [reviewed in (<a href="#B97" rid="B97" class=" bibr popnode">97</a>, <a href="#B98" rid="B98" class=" bibr popnode">98</a>)]. HER2-targeted therapies have been established in recent years, including tyrosine kinase inhibitors, such as lapatinib, neratinib, tucatinib, and pyrotinib (<a href="#B99" rid="B99" class=" bibr popnode">99</a>). Together, these drugs targeting multiple receptors, such as HER2, EGFR and HER4, were studied in the early and advanced stages of breast cancer and revealed some promising outcomes. Furthermore, in clinical trials, the combination of HER family inhibitors with endocrine therapy has been shown to have better results [reviewed in (<a href="#B100" rid="B100" class=" bibr popnode">100</a>)]. PRLR and EGFR/HER2 crosstalk, which greatly increases the activation of the RAS/ERK and PI3K/AKT pathways, are associated with poor prognosis and therapeutic resistance in breast tumor patients. In the case of PRLR, only a few attempts have successfully developed a potential therapeutic small molecule inhibitor or monoclonal antibody (LFA102) to block PRLR signaling induced cell proliferation in breast cancer cell lines (<a href="#B101" rid="B101" class=" bibr popnode">101</a>). Therefore, simultaneous treatments targeting both the HER2 and PRLR signaling cascades may offer better outcomes by efficiently hindering breast tumor progression and ameliorating endocrine resistance. A study using G129R (PRLR antagonist) and trastuzumab (monoclonal antibody targeting HER2) as a combination therapy to inhibit HER2+ breast cancer cells and a nude mouse xenograft model showed inhibition of cell proliferation (<a href="#B102" rid="B102" class=" bibr popnode">102</a>). Additionally, combining PI3K/AKT/mTOR pathway inhibitors with endocrine therapy has been shown to potentially reverse resistance to trastuzumab in HER2+ patients and metastatic breast cancer in early clinical trials. A rational combination of therapeutic agents based on the disease profile would be more beneficial to breast cancer patients [reviewed in (<a href="#B103" rid="B103" class=" bibr popnode">103</a>)].</p></div></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Concluding remarks</h2><p class="p p-first-last">PRL is a pleiotropic hormone that plays a crucial role in mammary gland development, lactogenesis, reproduction and immune function. It mediates its actions through PRLR, a member of the lactogen/cytokine receptor family. PRLR activation induces JAK/STAT and mitogen-activated protein kinase signaling pathways implicated in the development of mammary glands and etiology of breast cancer. In this review, we provide an overview of the current understanding of the complex organization of the human PRLR gene and its transcriptional regulation. Preclinical data, epidemiological studies, and patient tumor tissues analyses strongly support the contribution of PRL/PRLR to breast tumorigenesis and cancer progression. This review also stresses the importance of signal transduction pathways (PI3K/AKT, RAF/MEK/ERK, FAK, and SFK) activated by PRL/PRLR in breast cancer. We have summarized how steroid hormones (E2 and PR) and growth factors (EGF/ERBB1 and HER2) can induce the transcription of PRLR, thereby increasing its expression in breast cancer cells and promoting cell proliferation. Therefore, in this era of precision medicine, we conclude that combination therapy involving pathway-selective kinase inhibitors and PRLR inhibitors depending on the status of the breast cancer can provide better outcomes in clinical studies.</p></div><div id="s6" class="tsec sec"><h2 class="head no_bottom_margin" id="s6title">Authors contributions</h2><p class="p p-first-last">RK and MD were responsible for manuscript writing and editing. All authors contributed to the article and approved the submitted version.</p></div><div id="s7" class="tsec sec"><h2 class="head no_bottom_margin" id="s7title">Funding</h2><p class="p p-first-last">This work was supported by the National Institutes of Health Intramural Research Program through the Eunice Kennedy Shriver National Institute of Child Health and Human Development.</p></div><div id="s8" class="tsec sec"><h2 class="head no_bottom_margin" id="s8title">Acknowledgments</h2><p class="p p-first-last">The authors thank all laboratory members who participated in the studies covered by this review.</p></div><div id="s9" class="tsec sec"><h2 class="head no_bottom_margin" id="s9title">Conflict of interest</h2><p class="p p-first-last">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></div><div id="s10" class="tsec sec"><h2 class="head no_bottom_margin" id="s10title">Publisher&#x02019;s note</h2><p class="p p-first-last">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></div><div id="ref-list-a.l.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.l.atitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">
Bern HA, Nicoll CS. <span class="ref-title">The comparative endocrinology of prolactin</span>. <span class="ref-journal">Recent Prog Horm Res</span> (1968) <span class="ref-vol">24</span>:681&#x02013;720. doi: 10.1016/B978-1-4831-9827-9.50019-8
 [<a href="https://pubmed.ncbi.nlm.nih.gov/4882330" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FB978-1-4831-9827-9.50019-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Recent+Prog+Horm+Res&amp;title=The+comparative+endocrinology+of+prolactin&amp;author=HA+Bern&amp;author=CS+Nicoll&amp;volume=24&amp;publication_year=1968&amp;pages=681-720&amp;pmid=4882330&amp;doi=10.1016/B978-1-4831-9827-9.50019-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">
Freeman ME, Kanyicska B, Lerant A, Nagy G. <span class="ref-title">Prolactin: Structure, function, and regulation of secretion</span>. <span class="ref-journal">Physiol Rev</span> (2000) <span class="ref-vol">80</span>(<span class="ref-iss">4</span>):1523&#x02013;631. doi: 10.1152/physrev.2000.80.4.1523
 [<a href="https://pubmed.ncbi.nlm.nih.gov/11015620" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1152%2Fphysrev.2000.80.4.1523" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Rev&amp;title=Prolactin:+Structure,+function,+and+regulation+of+secretion&amp;author=ME+Freeman&amp;author=B+Kanyicska&amp;author=A+Lerant&amp;author=G+Nagy&amp;volume=80&amp;issue=4&amp;publication_year=2000&amp;doi=10.1152/physrev.2000.80.4.1523&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">
Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. <span class="ref-title">Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects</span>. <span class="ref-journal">Endocr Rev</span> (1996) <span class="ref-vol">17</span>(<span class="ref-iss">6</span>):639&#x02013;69. doi: 10.1210/edrv-17-6-639
 [<a href="https://pubmed.ncbi.nlm.nih.gov/8969972" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fedrv-17-6-639" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Extrapituitary+prolactin:+distribution,+regulation,+functions,+and+clinical+aspects&amp;author=N+Ben-Jonathan&amp;author=JL+Mershon&amp;author=DL+Allen&amp;author=RW+Steinmetz&amp;volume=17&amp;issue=6&amp;publication_year=1996&amp;doi=10.1210/edrv-17-6-639&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">
Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. <span class="ref-title">Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice</span>. <span class="ref-journal">Endocr Rev</span> (1998) <span class="ref-vol">19</span>(<span class="ref-iss">3</span>):225&#x02013;68. doi: 10.1210/edrv.19.3.0334
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9626554" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fedrv.19.3.0334" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Prolactin+(PRL)+and+its+receptor:+actions,+signal+transduction+pathways+and+phenotypes+observed+in+PRL+receptor+knockout+mice&amp;author=C+Bole-Feysot&amp;author=V+Goffin&amp;author=M+Edery&amp;author=N+Binart&amp;author=PA+Kelly&amp;volume=19&amp;issue=3&amp;publication_year=1998&amp;doi=10.1210/edrv.19.3.0334&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">
Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, et al.. <span class="ref-title">Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family</span>. <span class="ref-journal">Cell</span> (1988) <span class="ref-vol">53</span>(<span class="ref-iss">1</span>):69&#x02013;77. doi: 10.1016/0092-8674(88)90488-6
 [<a href="https://pubmed.ncbi.nlm.nih.gov/2832068" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0092-8674(88)90488-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Cloning+and+expression+of+the+rat+prolactin+receptor,+a+member+of+the+growth+hormone/prolactin+receptor+gene+family&amp;author=JM+Boutin&amp;author=C+Jolicoeur&amp;author=H+Okamura&amp;author=J+Gagnon&amp;author=M+Edery&amp;volume=53&amp;issue=1&amp;publication_year=1988&amp;pages=69-77&amp;pmid=2832068&amp;doi=10.1016/0092-8674(88)90488-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">
Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, et al.. <span class="ref-title">Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells</span>. <span class="ref-journal">Mol Endocrinol</span> (1989) <span class="ref-vol">3</span>(<span class="ref-iss">9</span>):1455&#x02013;61. doi: 10.1210/mend-3-9-1455
 [<a href="https://pubmed.ncbi.nlm.nih.gov/2558309" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fmend-3-9-1455" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Identification+of+a+cDNA+encoding+a+long+form+of+prolactin+receptor+in+human+hepatoma+and+breast+cancer+cells&amp;author=JM+Boutin&amp;author=M+Edery&amp;author=M+Shirota&amp;author=C+Jolicoeur&amp;author=L+Lesueur&amp;volume=3&amp;issue=9&amp;publication_year=1989&amp;doi=10.1210/mend-3-9-1455&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">
Zhang R, Buczko E, Tsai-Morris CH, Hu ZZ, Dufau ML. <span class="ref-title">Isolation and characterization of two novel rat ovarian lactogen receptor cDNA species</span>. <span class="ref-journal">Biochem Biophys Res Commun</span> (1990) <span class="ref-vol">168</span>(<span class="ref-iss">2</span>):415&#x02013;22. doi: 10.1016/0006-291X(90)92337-Y
 [<a href="https://pubmed.ncbi.nlm.nih.gov/2159291" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0006-291X(90)92337-Y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Isolation+and+characterization+of+two+novel+rat+ovarian+lactogen+receptor+cDNA+species&amp;author=R+Zhang&amp;author=E+Buczko&amp;author=CH+Tsai-Morris&amp;author=ZZ+Hu&amp;author=ML+Dufau&amp;volume=168&amp;issue=2&amp;publication_year=1990&amp;doi=10.1016/0006-291X(90)92337-Y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">
Bugge K, Papaleo E, Haxholm GW, Hopper JT, Robinson CV, Olsen JG, et al.. <span class="ref-title">A combined computational and structural model of the full-length human prolactin receptor</span>. <span class="ref-journal">Nat Commun</span> (2016) <span class="ref-vol">7</span>:11578. doi: 10.1038/ncomms11578
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4869255/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27174498" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fncomms11578" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=A+combined+computational+and+structural+model+of+the+full-length+human+prolactin+receptor&amp;author=K+Bugge&amp;author=E+Papaleo&amp;author=GW+Haxholm&amp;author=JT+Hopper&amp;author=CV+Robinson&amp;volume=7&amp;publication_year=2016&amp;pages=11578&amp;pmid=27174498&amp;doi=10.1038/ncomms11578&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">
Hu ZZ, Zhuang L, Meng J, Leondires M, Dufau ML. <span class="ref-title">The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N)</span>. <span class="ref-journal">J Clin Endocrinol Metab</span> (1999) <span class="ref-vol">84</span>(<span class="ref-iss">3</span>):1153&#x02013;6. doi: 10.1210/jcem.84.3.5659
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10084611" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fjcem.84.3.5659" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=The+human+prolactin+receptor+gene+structure+and+alternative+promoter+utilization:+the+generic+promoter+hPIII+and+a+novel+human+promoter+hP(N)&amp;author=ZZ+Hu&amp;author=L+Zhuang&amp;author=J+Meng&amp;author=M+Leondires&amp;author=ML+Dufau&amp;volume=84&amp;issue=3&amp;publication_year=1999&amp;doi=10.1210/jcem.84.3.5659&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">
Hu ZZ, Meng J, Dufau ML. <span class="ref-title">Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11</span>. <span class="ref-journal">J Biol Chem</span> (2001) <span class="ref-vol">276</span>(<span class="ref-iss">44</span>):41086&#x02013;94. doi: 10.1074/jbc.M102109200
 [<a href="https://pubmed.ncbi.nlm.nih.gov/11518703" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M102109200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Isolation+and+characterization+of+two+novel+forms+of+the+human+prolactin+receptor+generated+by+alternative+splicing+of+a+newly+identified+exon+11&amp;author=ZZ+Hu&amp;author=J+Meng&amp;author=ML+Dufau&amp;volume=276&amp;issue=44&amp;publication_year=2001&amp;doi=10.1074/jbc.M102109200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">
Brooks CL. <span class="ref-title">Molecular mechanisms of prolactin and its receptor</span>. <span class="ref-journal">Endocr Rev</span> (2012) <span class="ref-vol">33</span>(<span class="ref-iss">4</span>):504&#x02013;25. doi: 10.1210/er.2011-1040
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3410225/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22577091" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fer.2011-1040" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Molecular+mechanisms+of+prolactin+and+its+receptor&amp;author=CL+Brooks&amp;volume=33&amp;issue=4&amp;publication_year=2012&amp;doi=10.1210/er.2011-1040&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">
Kang JH, Hassan SA, Zhao P, Tsai-Morris CH, Dufau ML. <span class="ref-title">Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin</span>. <span class="ref-journal">Biochim Biophys Acta</span> (2014) <span class="ref-vol">1840</span>(<span class="ref-iss">7</span>):2272&#x02013;80. doi: 10.1016/j.bbagen.2014.04.006
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4061154/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24735798" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbagen.2014.04.006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Impact+of+subdomain+D1+of+the+short+form+S1b+of+the+human+prolactin+receptor+on+its+inhibitory+action+on+the+function+of+the+long+form+of+the+receptor+induced+by+prolactin&amp;author=JH+Kang&amp;author=SA+Hassan&amp;author=P+Zhao&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=1840&amp;issue=7&amp;publication_year=2014&amp;doi=10.1016/j.bbagen.2014.04.006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">
Clevenger CV, Furth PA, Hankinson SE, Schuler LA. <span class="ref-title">The role of prolactin in mammary carcinoma</span>. <span class="ref-journal">Endocr Rev</span> (2003) <span class="ref-vol">24</span>:1&#x02013;27. doi: 10.1210/er.2001-0036
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1698952/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12588805" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fer.2001-0036" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=The+role+of+prolactin+in+mammary+carcinoma&amp;author=CV+Clevenger&amp;author=PA+Furth&amp;author=SE+Hankinson&amp;author=LA+Schuler&amp;volume=24&amp;publication_year=2003&amp;pages=1-27&amp;pmid=12588805&amp;doi=10.1210/er.2001-0036&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">
Fernandez I, Touraine P, Goffin V. <span class="ref-title">Prolactin and human tumorigenesis</span>. <span class="ref-journal">J Endocr</span> (2010) <span class="ref-vol">22</span>:771&#x02013;7. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Endocr&amp;title=Prolactin+and+human+tumorigenesis&amp;author=I+Fernandez&amp;author=P+Touraine&amp;author=V+Goffin&amp;volume=22&amp;publication_year=2010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">
Ram&#x000ed;rez-de-Arellano A, Villegas-Pineda JC, Hern&#x000e1;ndez-Silva CD, Pereira-Su&#x000e1;rez AL. <span class="ref-title">The relevant participation of prolactin in the genesis and progression of gynecological cancers</span>. <span class="ref-journal">Front Endocrinol</span> (2021) <span class="ref-vol">12</span>:747810. doi: 10.3389/fendo.2021.747810
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8566755/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34745013" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffendo.2021.747810" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Endocrinol&amp;title=The+relevant+participation+of+prolactin+in+the+genesis+and+progression+of+gynecological+cancers&amp;author=A+Ram&#x000ed;rez-de-Arellano&amp;author=JC+Villegas-Pineda&amp;author=CD+Hern&#x000e1;ndez-Silva&amp;author=AL+Pereira-Su&#x000e1;rez&amp;volume=12&amp;publication_year=2021&amp;pages=747810&amp;doi=10.3389/fendo.2021.747810&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">
Buckley AR, Putnam CW, Russell DH. <span class="ref-title">Prolactin as a mammalian mitogen and tumor promoter</span>. <span class="ref-journal">Adv Enzyme Regul</span> (1988) <span class="ref-vol">27</span>:371&#x02013;91. doi:&#x000a0; 10.1016/0065-2571(88)90027-1
 [<a href="https://pubmed.ncbi.nlm.nih.gov/3250231" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0065-2571(88)90027-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Enzyme+Regul&amp;title=Prolactin+as+a+mammalian+mitogen+and+tumor+promoter&amp;author=AR+Buckley&amp;author=CW+Putnam&amp;author=DH+Russell&amp;volume=27&amp;publication_year=1988&amp;doi=10.1016/0065-2571(88)90027-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">
Tworoger SS, Hankinson SE. <span class="ref-title">Prolactin and breast cancer etiology: An epidemiologic perspective</span>. <span class="ref-journal">J Mammary Gland Biol Neoplasia</span> (2008) <span class="ref-vol">13</span>:41&#x02013;3. doi: 10.1007/s10911-008-9063-y
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18246319" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10911-008-9063-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mammary+Gland+Biol+Neoplasia&amp;title=Prolactin+and+breast+cancer+etiology:+An+epidemiologic+perspective&amp;author=SS+Tworoger&amp;author=SE+Hankinson&amp;volume=13&amp;publication_year=2008&amp;doi=10.1007/s10911-008-9063-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">
Bernichtein S, Touraine P, Goffin V. <span class="ref-title">New concepts in prolactin biology</span>. <span class="ref-journal">J Endocrinol</span> (2010) <span class="ref-vol">206</span>(<span class="ref-iss">1</span>):1&#x02013;11. doi: 10.1677/JOE-10-0069
 [<a href="https://pubmed.ncbi.nlm.nih.gov/20371569" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1677%2FJOE-10-0069" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Endocrinol&amp;title=New+concepts+in+prolactin+biology&amp;author=S+Bernichtein&amp;author=P+Touraine&amp;author=V+Goffin&amp;volume=206&amp;issue=1&amp;publication_year=2010&amp;pages=1-11&amp;pmid=20371569&amp;doi=10.1677/JOE-10-0069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">
Goffin V. <span class="ref-title">Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge</span>. <span class="ref-journal">Pharmacol Ther</span> (2017) <span class="ref-vol">179</span>:111&#x02013;26. doi: 10.1016/j.pharmthera.2017.05.009
 [<a href="https://pubmed.ncbi.nlm.nih.gov/28549597" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.pharmthera.2017.05.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;title=Prolactin+receptor+targeting+in+breast+and+prostate+cancers:+New+insights+into+an+old+challenge&amp;author=V+Goffin&amp;volume=179&amp;publication_year=2017&amp;doi=10.1016/j.pharmthera.2017.05.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">
Tworoger SS, Eliassen AH, Zhang X, Qian J, Sluss PM, Rosner BA, et al.. <span class="ref-title">A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development</span>. <span class="ref-journal">Cancer Res</span> (2013) <span class="ref-vol">73</span>:4810&#x02013;9. doi: 10.1158/0008-5472.CAN-13-0665
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3738582/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23783576" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-13-0665" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=A+20-year+prospective+study+of+plasma+prolactin+as+a+risk+marker+of+breast+cancer+development&amp;author=SS+Tworoger&amp;author=AH+Eliassen&amp;author=X+Zhang&amp;author=J+Qian&amp;author=PM+Sluss&amp;volume=73&amp;publication_year=2013&amp;doi=10.1158/0008-5472.CAN-13-0665&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">
O'Sullivan CC, Bates SE. <span class="ref-title">Targeting prolactin receptor (PRLR) signaling in PRLR-positive breast and prostate cancer</span>. <span class="ref-journal">Oncol</span> (2016) <span class="ref-vol">21,5</span>:523&#x02013;6. doi: 10.1634/theoncologist.2016-0108
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4861375/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27107001" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1634%2Ftheoncologist.2016-0108" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol&amp;title=Targeting+prolactin+receptor+(PRLR)+signaling+in+PRLR-positive+breast+and+prostate+cancer&amp;author=CC+O'Sullivan&amp;author=SE+Bates&amp;volume=21,5&amp;publication_year=2016&amp;doi=10.1634/theoncologist.2016-0108&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">
Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, et al.. <span class="ref-title">Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors</span>. <span class="ref-journal">Proc Natl Acad Sci U.S.A.</span> (2008) <span class="ref-vol">105</span>(<span class="ref-iss">38</span>):14533&#x02013;8. doi: 10.1073/pnas.0800685105
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2567233/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18779591" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.0800685105" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U.S.A.&amp;title=Identification+of+a+gain-of-function+mutation+of+the+prolactin+receptor+in+women+with+benign+breast+tumors&amp;author=RL+Bogorad&amp;author=C+Courtillot&amp;author=C+Mestayer&amp;author=S+Bernichtein&amp;author=L+Harutyunyan&amp;volume=105&amp;issue=38&amp;publication_year=2008&amp;doi=10.1073/pnas.0800685105&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">
Ouhtit A, Morel G, Kelly PA. <span class="ref-title">Visualization of gene expression of short and long forms of prolactin receptor in the rat</span>. <span class="ref-journal">Endocrinology</span> (1993) <span class="ref-vol">133</span>(<span class="ref-iss">1</span>):135&#x02013;44. doi: 10.1210/endo.133.1.8319561
 [<a href="https://pubmed.ncbi.nlm.nih.gov/8319561" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fendo.133.1.8319561" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Visualization+of+gene+expression+of+short+and+long+forms+of+prolactin+receptor+in+the+rat&amp;author=A+Ouhtit&amp;author=G+Morel&amp;author=PA+Kelly&amp;volume=133&amp;issue=1&amp;publication_year=1993&amp;doi=10.1210/endo.133.1.8319561&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">
Royster M, Driscoll P, Kelly PA, Freemark M. <span class="ref-title">The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation</span>. <span class="ref-journal">Endocrinology</span> (1995) <span class="ref-vol">136</span>(<span class="ref-iss">9</span>):3892&#x02013;900. doi: 10.1210/endo.136.9.7649097
 [<a href="https://pubmed.ncbi.nlm.nih.gov/7649097" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fendo.136.9.7649097" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=The+prolactin+receptor+in+the+fetal+rat:+cellular+localization+of+messenger+ribonucleic+acid,+immunoreactive+protein,+and+ligand-binding+activity+and+induction+of+expression+in+late+gestation&amp;author=M+Royster&amp;author=P+Driscoll&amp;author=PA+Kelly&amp;author=M+Freemark&amp;volume=136&amp;issue=9&amp;publication_year=1995&amp;doi=10.1210/endo.136.9.7649097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">
Dagil R, Knudsen MJ, Olsen JG, O'Shea C, Franzmann M, Goffin V, et al.. <span class="ref-title">The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor</span>. <span class="ref-journal">Structure</span> (2012) <span class="ref-vol">20</span>(<span class="ref-iss">2</span>):270&#x02013;82. doi: 10.1016/j.str.2011.12.010
 [<a href="https://pubmed.ncbi.nlm.nih.gov/22325776" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.str.2011.12.010" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Structure&amp;title=The+WSXWS+motif+in+cytokine+receptors+is+a+molecular+switch+involved+in+receptor+activation:+insight+from+structures+of+the+prolactin+receptor&amp;author=R+Dagil&amp;author=MJ+Knudsen&amp;author=JG+Olsen&amp;author=C+O'Shea&amp;author=M+Franzmann&amp;volume=20&amp;issue=2&amp;publication_year=2012&amp;doi=10.1016/j.str.2011.12.010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">
Haxholm GW, Nikolajsen LF, Olsen JG, Fredsted J, Larsen FH, Goffin V, et al.. <span class="ref-title">Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes</span>. <span class="ref-journal">Biochem J</span> (2015) <span class="ref-vol">468</span>(<span class="ref-iss">3</span>):495&#x02013;506. doi: 10.1042/BJ20141243
 [<a href="https://pubmed.ncbi.nlm.nih.gov/25846210" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2FBJ20141243" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;title=Intrinsically+disordered+cytoplasmic+domains+of+two+cytokine+receptors+mediate+conserved+interactions+with+membranes&amp;author=GW+Haxholm&amp;author=LF+Nikolajsen&amp;author=JG+Olsen&amp;author=J+Fredsted&amp;author=FH+Larsen&amp;volume=468&amp;issue=3&amp;publication_year=2015&amp;pages=495-506&amp;pmid=25846210&amp;doi=10.1042/BJ20141243&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">
Tsai-Morris CH, Dufau ML. <span class="ref-title">PRLR (prolactin receptor)</span>. In: <span class="ref-journal">Atlas Genet cytogenet oncol haematol</span> (2011). Available at: <a href="http://atlasgeneticsoncology.org/gene/42891/">http://atlasgeneticsoncology.org/gene/42891/</a>
 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Atlas+Genet+cytogenet+oncol+haematol&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;publication_year=2011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">
Ali S, Pellegrini I, Kelly PA. <span class="ref-title">A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor</span>. <span class="ref-journal">J Biol Chem</span> (1991) <span class="ref-vol">266</span>(<span class="ref-iss">30</span>):20110&#x02013;7. doi: 10.1016/S0021-9258(18)54897-3
 [<a href="https://pubmed.ncbi.nlm.nih.gov/1718958" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0021-9258(18)54897-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+prolactin-dependent+immune+cell+line+(Nb2)+expresses+a+mutant+form+of+prolactin+receptor&amp;author=S+Ali&amp;author=I+Pellegrini&amp;author=PA+Kelly&amp;volume=266&amp;issue=30&amp;publication_year=1991&amp;doi=10.1016/S0021-9258(18)54897-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">
Grible JM, Zot P, Olex AL, Hedrick SE, Harrell JC, Woock AE, et al.. <span class="ref-title">The human intermediate prolactin receptor is a mammary proto-oncogene</span>. <span class="ref-journal">NPJ Breast Cancer</span> (2021) <span class="ref-vol">7</span>(<span class="ref-iss">1</span>):37. doi: 10.1038/s41523-021-00243-7
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7997966/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33772010" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41523-021-00243-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=NPJ+Breast+Cancer&amp;title=The+human+intermediate+prolactin+receptor+is+a+mammary+proto-oncogene&amp;author=JM+Grible&amp;author=P+Zot&amp;author=AL+Olex&amp;author=SE+Hedrick&amp;author=JC+Harrell&amp;volume=7&amp;issue=1&amp;publication_year=2021&amp;pages=37&amp;pmid=33772010&amp;doi=10.1038/s41523-021-00243-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">
Pujianto DA, Curry BJ, Aitken RJ. <span class="ref-title">Prolactin exerts a prosurvival effect on human spermatozoa <em>via</em> mechanisms that involve the stimulation of akt phosphorylation and suppression of caspase activation and capacitation</span>. <span class="ref-journal">Endocrinology</span> (2010) <span class="ref-vol">151</span>(<span class="ref-iss">3</span>):1269&#x02013;79. doi: 10.1210/en.2009-0964
 [<a href="https://pubmed.ncbi.nlm.nih.gov/20032052" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fen.2009-0964" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Prolactin+exerts+a+prosurvival+effect+on+human+spermatozoa+via+mechanisms+that+involve+the+stimulation+of+akt+phosphorylation+and+suppression+of+caspase+activation+and+capacitation&amp;author=DA+Pujianto&amp;author=BJ+Curry&amp;author=RJ+Aitken&amp;volume=151&amp;issue=3&amp;publication_year=2010&amp;doi=10.1210/en.2009-0964&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">
Qazi AM, Tsai-Morris CH, Dufau ML. <span class="ref-title">Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization</span>. <span class="ref-journal">Mol Endocrinol</span> (2006) <span class="ref-vol">20</span>(<span class="ref-iss">8</span>):1912&#x02013;23. doi: 10.1210/me.2005-0291
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16556730" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fme.2005-0291" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Ligand-independent+homo-+and+heterodimerization+of+human+prolactin+receptor+variants:+inhibitory+action+of+the+short+forms+by+heterodimerization&amp;author=AM+Qazi&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=20&amp;issue=8&amp;publication_year=2006&amp;doi=10.1210/me.2005-0291&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">
Tan D, Walker AM. <span class="ref-title">Short form 1b human prolactin receptor down-regulates expression of the long form</span>. <span class="ref-journal">J Mol Endocrinol</span> (2010) <span class="ref-vol">44</span>(<span class="ref-iss">3</span>):187&#x02013;94. doi: 10.1677/JME-09-0101
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19906835" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1677%2FJME-09-0101" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Endocrinol&amp;title=Short+form+1b+human+prolactin+receptor+down-regulates+expression+of+the+long+form&amp;author=D+Tan&amp;author=AM+Walker&amp;volume=44&amp;issue=3&amp;publication_year=2010&amp;doi=10.1677/JME-09-0101&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="mixed-citation">
Tan D, Huang KT, Ueda E, Walker AM. <span class="ref-title">S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain</span>. <span class="ref-journal">Biochemistry</span> (2008) <span class="ref-vol">47</span>(<span class="ref-iss">1</span>):479&#x02013;89. doi: 10.1021/bi7013882
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2408824/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18081308" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Fbi7013882" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=S2+deletion+variants+of+human+PRL+receptors+demonstrate+that+extracellular+domain+conformation+can+alter+conformation+of+the+intracellular+signaling+domain&amp;author=D+Tan&amp;author=KT+Huang&amp;author=E+Ueda&amp;author=AM+Walker&amp;volume=47&amp;issue=1&amp;publication_year=2008&amp;doi=10.1021/bi7013882&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="mixed-citation">
Binart N, Bachelot A, Bouilly J. <span class="ref-title">Impact of prolactin receptor isoforms on reproduction</span>. <span class="ref-journal">Trends Endocrinol Metab</span> (2010) <span class="ref-vol">21</span>(<span class="ref-iss">6</span>):362&#x02013;8. doi: 10.1016/j.tem.2010.01.008
 [<a href="https://pubmed.ncbi.nlm.nih.gov/20149678" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tem.2010.01.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Endocrinol+Metab&amp;title=Impact+of+prolactin+receptor+isoforms+on+reproduction&amp;author=N+Binart&amp;author=A+Bachelot&amp;author=J+Bouilly&amp;volume=21&amp;issue=6&amp;publication_year=2010&amp;doi=10.1016/j.tem.2010.01.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="mixed-citation">
Meng J, Tsai-Morris CH, Dufau ML. <span class="ref-title">Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma</span>. <span class="ref-journal">Cancer Res</span> (2004) <span class="ref-vol">64</span>(<span class="ref-iss">16</span>):5677&#x02013;82. doi: 10.1158/0008-5472.CAN-04-1019
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15313907" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-04-1019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Human+prolactin+receptor+variants+in+breast+cancer:+low+ratio+of+short+forms+to+the+long-form+human+prolactin+receptor+associated+with+mammary+carcinoma&amp;author=J+Meng&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=64&amp;issue=16&amp;publication_year=2004&amp;doi=10.1158/0008-5472.CAN-04-1019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="mixed-citation">
Xie YL, Hassan SA, Qazi AM, Tsai-Morris CH, Dufau ML. <span class="ref-title">Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor</span>. <span class="ref-journal">Mol Cell Biol</span> (2009) <span class="ref-vol">29</span>(<span class="ref-iss">10</span>):2546&#x02013;55. doi: 10.1128/MCB.01716-08
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2682051/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19273600" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.01716-08" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Intramolecular+disulfide+bonds+of+the+prolactin+receptor+short+form+are+required+for+its+inhibitory+action+on+the+function+of+the+long+form+of+the+receptor&amp;author=YL+Xie&amp;author=SA+Hassan&amp;author=AM+Qazi&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=29&amp;issue=10&amp;publication_year=2009&amp;doi=10.1128/MCB.01716-08&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="mixed-citation">
Devi YS, Shehu A, Halperin J, Stocco C, Le J, Seibold AM, et al.. <span class="ref-title">Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues</span>. <span class="ref-journal">Reprod Biol Endocrinol</span> (2009) <span class="ref-vol">7</span>:87. doi: 10.1186/1477-7827-7-87
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2746216/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19703295" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1477-7827-7-87" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Reprod+Biol+Endocrinol&amp;title=Prolactin+signaling+through+the+short+isoform+of+the+mouse+prolactin+receptor+regulates+DNA+binding+of+specific+transcription+factors,+often+with+opposite+effects+in+different+reproductive+issues&amp;author=YS+Devi&amp;author=A+Shehu&amp;author=J+Halperin&amp;author=C+Stocco&amp;author=J+Le&amp;volume=7&amp;publication_year=2009&amp;pages=87&amp;pmid=19703295&amp;doi=10.1186/1477-7827-7-87&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="mixed-citation">
Hu ZZ, Zhuang L. <span class="ref-title">Dufau prolactin receptor gene diversity: Structure and regulation</span>. <span class="ref-journal">Trends Endocrinol Metab</span> (1998) <span class="ref-vol">9</span>:94&#x02013;102. doi: 10.1016/S1043-2760(98)00027-7
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18406249" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS1043-2760(98)00027-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Endocrinol+Metab&amp;title=Dufau+prolactin+receptor+gene+diversity:+Structure+and+regulation&amp;author=ZZ+Hu&amp;author=L+Zhuang&amp;volume=9&amp;publication_year=1998&amp;pages=94-102&amp;pmid=18406249&amp;doi=10.1016/S1043-2760(98)00027-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="mixed-citation">
Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH, Dufau ML. <span class="ref-title">Complex 5' genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization</span>. <span class="ref-journal">Endocrinology</span> (2002) <span class="ref-vol">143</span>(<span class="ref-iss">6</span>):2139&#x02013;42. doi: 10.1210/endo.143.6.8949
 [<a href="https://pubmed.ncbi.nlm.nih.gov/12021177" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fendo.143.6.8949" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Complex+5'+genomic+structure+of+the+human+prolactin+receptor:+multiple+alternative+exons+1+and+promoter+utilization&amp;author=ZZ+Hu&amp;author=L+Zhuang&amp;author=J+Meng&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=143&amp;issue=6&amp;publication_year=2002&amp;doi=10.1210/endo.143.6.8949&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="mixed-citation">
Dong J, Tsai-Morris CH, Dufau ML. <span class="ref-title">A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor</span>. <span class="ref-journal">J Biol Chem</span> (2006) <span class="ref-vol">281</span>(<span class="ref-iss">27</span>):18825&#x02013;36. doi: 10.1074/jbc.M512826200
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16651265" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M512826200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+novel+estradiol/estrogen+receptor+alpha-dependent+transcriptional+mechanism+controls+expression+of+the+human+prolactin+receptor&amp;author=J+Dong&amp;author=CH+Tsai-Morris&amp;author=ML+Dufau&amp;volume=281&amp;issue=27&amp;publication_year=2006&amp;doi=10.1074/jbc.M512826200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="mixed-citation">
Kang J-H, Tsai-Morris C-H, Dufau ML. <span class="ref-title">Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription</span>. <span class="ref-journal">Mol Cell Biol</span> (2011) <span class="ref-vol">31</span>(<span class="ref-iss">16</span>):3208&#x02013;22. doi: 10.1128/MCB.05337-11
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3147787/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21670145" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.05337-11" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Complex+formation+and+interactions+between+transcription+factors+essential+for+human+prolactin+receptor+gene+transcription&amp;author=J-H+Kang&amp;author=C-H+Tsai-Morris&amp;author=ML+Dufau&amp;volume=31&amp;issue=16&amp;publication_year=2011&amp;doi=10.1128/MCB.05337-11&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="mixed-citation">
Gutzman JH, Miller KK, Schuler LA. <span class="ref-title">Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells</span>. <span class="ref-journal">J Steroid Biochem Mol Biol</span> (2004) <span class="ref-vol">88</span>(<span class="ref-iss">1</span>):69&#x02013;77. doi: 10.1016/j.jsbmb.2003.10.008
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15026085" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jsbmb.2003.10.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Steroid+Biochem+Mol+Biol&amp;title=Endogenous+human+prolactin+and+not+exogenous+human+prolactin+induces+estrogen+receptor+alpha+and+prolactin+receptor+expression+and+increases+estrogen+responsiveness+in+breast+cancer+cells&amp;author=JH+Gutzman&amp;author=KK+Miller&amp;author=LA+Schuler&amp;volume=88&amp;issue=1&amp;publication_year=2004&amp;pages=69-77&amp;pmid=15026085&amp;doi=10.1016/j.jsbmb.2003.10.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="mixed-citation">
Goldhar AS, Duan R, Ginsburg E, Vonderhaar BK. <span class="ref-title">Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP</span>. <span class="ref-journal">Mol Cell Endocrinol</span> (2011) <span class="ref-vol">335</span>(<span class="ref-iss">2</span>):148&#x02013;57. doi: 10.1016/j.mce.2011.01.004
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3045478/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21238538" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mce.2011.01.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Endocrinol&amp;title=Progesterone+induces+expression+of+the+prolactin+receptor+gene+through+cooperative+action+of+Sp1+and+C/EBP&amp;author=AS+Goldhar&amp;author=R+Duan&amp;author=E+Ginsburg&amp;author=BK+Vonderhaar&amp;volume=335&amp;issue=2&amp;publication_year=2011&amp;doi=10.1016/j.mce.2011.01.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="mixed-citation">
Kavarthapu R, Anbazhagan R, Dufau ML. <span class="ref-title">Crosstalk between PRLR and EGFR/HER2 signaling pathways in breast cancer</span>. <span class="ref-journal">Cancers (Basel)</span> (2021) <span class="ref-vol">13</span>(<span class="ref-iss">18</span>):4685. doi: 10.3390/cancers13184685
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8467304/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34572912" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcancers13184685" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancers+(Basel)&amp;title=Crosstalk+between+PRLR+and+EGFR/HER2+signaling+pathways+in+breast+cancer&amp;author=R+Kavarthapu&amp;author=R+Anbazhagan&amp;author=ML+Dufau&amp;volume=13&amp;issue=18&amp;publication_year=2021&amp;pages=4685&amp;pmid=34572912&amp;doi=10.3390/cancers13184685&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="mixed-citation">
Lebrun JJ, Ali S, Goffin V, Ullrich A, Kelly PA. <span class="ref-title">A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription</span>. <span class="ref-journal">Proc Natl Acad Sci U.S.A.</span> (1995) <span class="ref-vol">92</span>(<span class="ref-iss">9</span>):4031&#x02013;5. doi: 10.1073/pnas.92.9.4031
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC42096/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7537382" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.92.9.4031" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U.S.A.&amp;title=A+single+phosphotyrosine+residue+of+the+prolactin+receptor+is+responsible+for+activation+of+gene+transcription&amp;author=JJ+Lebrun&amp;author=S+Ali&amp;author=V+Goffin&amp;author=A+Ullrich&amp;author=PA+Kelly&amp;volume=92&amp;issue=9&amp;publication_year=1995&amp;doi=10.1073/pnas.92.9.4031&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="mixed-citation">
Finidori J, Kelly PA. <span class="ref-title">Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription</span>. <span class="ref-journal">J Endocrinol</span> (1995) <span class="ref-vol">147</span>(<span class="ref-iss">1</span>):11&#x02013;23. doi: 10.1677/joe.0.1470011
 [<a href="https://pubmed.ncbi.nlm.nih.gov/7490523" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1677%2Fjoe.0.1470011" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Endocrinol&amp;title=Cytokine+receptor+signalling+through+two+novel+families+of+transducer+molecules:+Janus+kinases,+and+signal+transducers+and+activators+of+transcription&amp;author=J+Finidori&amp;author=PA+Kelly&amp;volume=147&amp;issue=1&amp;publication_year=1995&amp;pages=11-23&amp;pmid=7490523&amp;doi=10.1677/joe.0.1470011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="mixed-citation">
Horseman ND, Yu-Lee LY. <span class="ref-title">Transcriptional regulation by the helix bundle peptide hormones: Growth hormone, prolactin, and hematopoietic cytokines</span>. <span class="ref-journal">Endocr Rev</span> (1994) <span class="ref-vol">15</span>(<span class="ref-iss">5</span>):627&#x02013;49. doi: 10.1210/edrv-15-5-627
 [<a href="https://pubmed.ncbi.nlm.nih.gov/7843070" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fedrv-15-5-627" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Transcriptional+regulation+by+the+helix+bundle+peptide+hormones:+Growth+hormone,+prolactin,+and+hematopoietic+cytokines&amp;author=ND+Horseman&amp;author=LY+Yu-Lee&amp;volume=15&amp;issue=5&amp;publication_year=1994&amp;doi=10.1210/edrv-15-5-627&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="mixed-citation">
Ihle JN. <span class="ref-title">STATs: signal transducers and activators of transcription</span>. <span class="ref-journal">Cell</span> (1996) <span class="ref-vol">84</span>(<span class="ref-iss">3</span>):331&#x02013;4. doi: 10.1016/S0092-8674(00)81277-5
 [<a href="https://pubmed.ncbi.nlm.nih.gov/8608586" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0092-8674(00)81277-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=STATs:+signal+transducers+and+activators+of+transcription&amp;author=JN+Ihle&amp;volume=84&amp;issue=3&amp;publication_year=1996&amp;doi=10.1016/S0092-8674(00)81277-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="mixed-citation">
Das R, Vonderhaar BK. <span class="ref-title">Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells</span>. <span class="ref-journal">Oncogene</span> (1996) <span class="ref-vol">13</span>(<span class="ref-iss">6</span>):1139&#x02013;45. [<a href="https://pubmed.ncbi.nlm.nih.gov/8808687" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Involvement+of+SHC,+GRB2,+SOS+and+RAS+in+prolactin+signal+transduction+in+mammary+epithelial+cells&amp;author=R+Das&amp;author=BK+Vonderhaar&amp;volume=13&amp;issue=6&amp;publication_year=1996&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="mixed-citation">
Das R, Vonderhaar BK. <span class="ref-title">Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells</span>. <span class="ref-journal">Breast Cancer Res Treat</span> (1996) <span class="ref-vol">40</span>(<span class="ref-iss">2</span>):141&#x02013;9. doi: 10.1007/BF01806209
 [<a href="https://pubmed.ncbi.nlm.nih.gov/8879680" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2FBF01806209" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Activation+of+raf-1,+MEK,+and+MAP+kinase+in+prolactin+responsive+mammary+cells&amp;author=R+Das&amp;author=BK+Vonderhaar&amp;volume=40&amp;issue=2&amp;publication_year=1996&amp;doi=10.1007/BF01806209&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="mixed-citation">
Ihle JN. <span class="ref-title">STATs and MAPKs: Obligate or opportunistic partners in signaling</span>. <span class="ref-journal">Bioessays</span> (1996) <span class="ref-vol">18</span>(<span class="ref-iss">2</span>):95&#x02013;8. doi: 10.1002/bies.950180204
 [<a href="https://pubmed.ncbi.nlm.nih.gov/8851041" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fbies.950180204" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioessays&amp;title=STATs+and+MAPKs:+Obligate+or+opportunistic+partners+in+signaling&amp;author=JN+Ihle&amp;volume=18&amp;issue=2&amp;publication_year=1996&amp;doi=10.1002/bies.950180204&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="mixed-citation">
al-Sakkaf KA, Dobson PR, Brown BL. <span class="ref-title">Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidylinositol 3-kinase activation in Nb2 cells</span>. <span class="ref-journal">J Mol Endocrinol</span> (1997) <span class="ref-vol">19</span>(<span class="ref-iss">3</span>):347&#x02013;50. doi: 10.1677/jme.0.0190347
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9460655" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1677%2Fjme.0.0190347" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Endocrinol&amp;title=Prolactin+induced+tyrosine+phosphorylation+of+p59fyn+may+mediate+phosphatidylinositol+3-kinase+activation+in+Nb2+cells&amp;author=KA+al-Sakkaf&amp;author=PR+Dobson&amp;author=BL+Brown&amp;volume=19&amp;issue=3&amp;publication_year=1997&amp;doi=10.1677/jme.0.0190347&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="mixed-citation">
Miller SL, DeMaria JE, Freier DO, Riegel AM, Clevenger CV. <span class="ref-title">Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor</span>. <span class="ref-journal">Mol Endocrinol</span> (2005) <span class="ref-vol">19</span>(<span class="ref-iss">4</span>):939&#x02013;49. doi: 10.1210/me.2004-0443
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15618286" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fme.2004-0443" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Novel+association+of+Vav2+and+Nek3+modulates+signaling+through+the+human+prolactin+receptor&amp;author=SL+Miller&amp;author=JE+DeMaria&amp;author=DO+Freier&amp;author=AM+Riegel&amp;author=CV+Clevenger&amp;volume=19&amp;issue=4&amp;publication_year=2005&amp;doi=10.1210/me.2004-0443&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="mixed-citation">
Miller SL, Antico G, Raghunath PN, Tomaszewski JE, Clevenger CV. <span class="ref-title">Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells</span>. <span class="ref-journal">Oncogene</span> (2007) <span class="ref-vol">26</span>(<span class="ref-iss">32</span>):4668&#x02013;78. doi: 10.1038/sj.onc.1210264
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17297458" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1210264" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Nek3+kinase+regulates+prolactin-mediated+cytoskeletal+reorganization+and+motility+of+breast+cancer+cells&amp;author=SL+Miller&amp;author=G+Antico&amp;author=PN+Raghunath&amp;author=JE+Tomaszewski&amp;author=CV+Clevenger&amp;volume=26&amp;issue=32&amp;publication_year=2007&amp;doi=10.1038/sj.onc.1210264&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="mixed-citation">
Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. <span class="ref-title">Expression of prolactin and its receptor in human breast carcinoma</span>. <span class="ref-journal">Endocrinology</span> (1997) <span class="ref-vol">138</span>:5555&#x02013;60. doi: 10.1210/endo.138.12.5605
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9389544" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fendo.138.12.5605" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Expression+of+prolactin+and+its+receptor+in+human+breast+carcinoma&amp;author=C+Reynolds&amp;author=KT+Montone&amp;author=CM+Powell&amp;author=JE+Tomaszewski&amp;author=CV+Clevenger&amp;volume=138&amp;publication_year=1997&amp;doi=10.1210/endo.138.12.5605&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="mixed-citation">
Gorvin CM. <span class="ref-title">The prolactin receptor: Diverse and emerging roles in pathophysiology</span>. <span class="ref-journal">J Clin Transl Endocrinol</span> (2015) <span class="ref-vol">2</span>(<span class="ref-iss">3</span>):85&#x02013;91. doi: 10.1016/j.jcte.2015.05.001
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5685068/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29204371" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jcte.2015.05.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Transl+Endocrinol&amp;title=The+prolactin+receptor:+Diverse+and+emerging+roles+in+pathophysiology&amp;author=CM+Gorvin&amp;volume=2&amp;issue=3&amp;publication_year=2015&amp;pages=85-91&amp;pmid=29204371&amp;doi=10.1016/j.jcte.2015.05.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="mixed-citation">
Tran-Thanh D, Arneson NC, Pintilie M, Deliallisi A, Warren KS, Bane A, et al.. <span class="ref-title">Amplification of the prolactin receptor gene in mammary lobular neoplasia</span>. <span class="ref-journal">Breast Cancer Res Treat</span> (2011) <span class="ref-vol">128</span>:31&#x02013;40. doi: 10.1007/s10549-010-1025-6
 [<a href="https://pubmed.ncbi.nlm.nih.gov/20658264" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10549-010-1025-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Amplification+of+the+prolactin+receptor+gene+in+mammary+lobular+neoplasia&amp;author=D+Tran-Thanh&amp;author=NC+Arneson&amp;author=M+Pintilie&amp;author=A+Deliallisi&amp;author=KS+Warren&amp;volume=128&amp;publication_year=2011&amp;pages=31-40&amp;pmid=20658264&amp;doi=10.1007/s10549-010-1025-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="mixed-citation">
Tikk K, Sookthai D, Johnson T, Rinaldi S, Romieu I, Tj&#x000f8;nneland A, et al.. <span class="ref-title">Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort</span>. <span class="ref-journal">Ann Oncol</span> (2014) <span class="ref-vol">25</span>(<span class="ref-iss">7</span>):1422&#x02013;8. doi: 10.1093/annonc/mdu150 Rinaldi S, Romieu I, Tj&#x000f8;nneland A
 [<a href="https://pubmed.ncbi.nlm.nih.gov/24718887" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fannonc%2Fmdu150" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Circulating+prolactin+and+breast+cancer+risk+among+pre-+and+postmenopausal+women+in+the+EPIC+cohort&amp;author=K+Tikk&amp;author=D+Sookthai&amp;author=T+Johnson&amp;author=S+Rinaldi&amp;author=I+Romieu&amp;volume=25&amp;issue=7&amp;publication_year=2014&amp;doi=10.1093/annonc/mdu150&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="mixed-citation">
Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C. <span class="ref-title">Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women</span>. <span class="ref-journal">J Natl Cancer Inst</span> (1999) <span class="ref-vol">91</span>:629&#x02013;34. doi: 10.1093/jnci/91.7.629
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10203283" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fjnci%2F91.7.629" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Plasma+prolactin+levels+and+subsequent+risk+of+breast+cancer+in+postmenopausal+women&amp;author=SE+Hankinson&amp;author=WC+Willett&amp;author=DS+Michaud&amp;author=JE+Manson&amp;author=GA+Colditz&amp;volume=91&amp;publication_year=1999&amp;doi=10.1093/jnci/91.7.629&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60">60. <span class="mixed-citation">
Tworoger SS, Hankinson SE. <span class="ref-title">Prolactin and breast cancer risk</span>. <span class="ref-journal">Cancer Lett</span> (2006) <span class="ref-vol">243</span>:160&#x02013;9. doi: 10.1016/j.canlet.2006.01.032
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16530327" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.canlet.2006.01.032" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Prolactin+and+breast+cancer+risk&amp;author=SS+Tworoger&amp;author=SE+Hankinson&amp;volume=243&amp;publication_year=2006&amp;doi=10.1016/j.canlet.2006.01.032&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61">61. <span class="mixed-citation">
Tworoger SS, Sluss P, Hankinson SE. <span class="ref-title">Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women</span>. <span class="ref-journal">Cancer Res</span> (2006) <span class="ref-vol">66</span>:2476&#x02013;82. doi: 10.1158/0008-5472.CAN-05-3369
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16489055" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-05-3369" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Association+between+plasma+prolactin+concentrations+and+risk+of+breast+cancer+among+predominately+premenopausal+women&amp;author=SS+Tworoger&amp;author=P+Sluss&amp;author=SE+Hankinson&amp;volume=66&amp;publication_year=2006&amp;doi=10.1158/0008-5472.CAN-05-3369&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62">62. <span class="mixed-citation">
Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. <span class="ref-title">A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer</span>. <span class="ref-journal">J Clin Oncol</span> (2007) <span class="ref-vol">25</span>:1482&#x02013;8. doi: 10.1200/JCO.2006.07.6356
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17372279" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2006.07.6356" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=A+prospective+study+of+plasma+prolactin+concentrations+and+risk+of+premenopausal+and+postmenopausal+breast+cancer&amp;author=SS+Tworoger&amp;author=AH+Eliassen&amp;author=P+Sluss&amp;author=SE+Hankinson&amp;volume=25&amp;publication_year=2007&amp;doi=10.1200/JCO.2006.07.6356&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63">63. <span class="mixed-citation">
Ferreira M, Mesquita M, Quaresma M, Andr&#x000e9; S. <span class="ref-title">Prolactin receptor expression in gynaecomastia and male breast carcinoma</span>. <span class="ref-journal">Histopathology</span> (2008) <span class="ref-vol">53</span>(<span class="ref-iss">1</span>):56&#x02013;61. doi: 10.1111/j.1365-2559.2008.03059.x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18613925" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1365-2559.2008.03059.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Histopathology&amp;title=Prolactin+receptor+expression+in+gynaecomastia+and+male+breast+carcinoma&amp;author=M+Ferreira&amp;author=M+Mesquita&amp;author=M+Quaresma&amp;author=S+Andr&#x000e9;&amp;volume=53&amp;issue=1&amp;publication_year=2008&amp;pages=56-61&amp;pmid=18613925&amp;doi=10.1111/j.1365-2559.2008.03059.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64">64. <span class="mixed-citation">
O&#x02019;Leary KA, Shea MP, Schuler LA. <span class="ref-title">Modeling prolactin actions in breast cancer <em>in vivo</em>: Insights from the NRL-PRL mouse</span>. <span class="ref-journal">Adv Exp Med Biol</span> (2015) <span class="ref-vol">846</span>:201&#x02013;20. doi: 10.1007/978-3-319-12114-7_9
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4770878/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25472540" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2F978-3-319-12114-7_9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Modeling+prolactin+actions+in+breast+cancer+in+vivo:+Insights+from+the+NRL-PRL+mouse&amp;author=KA+O&#x02019;Leary&amp;author=MP+Shea&amp;author=LA+Schuler&amp;volume=846&amp;publication_year=2015&amp;doi=10.1007/978-3-319-12114-7_9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65">65. <span class="mixed-citation">
Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. <span class="ref-title">Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice</span>. <span class="ref-journal">Oncogene</span> (2003) <span class="ref-vol">22</span>(<span class="ref-iss">30</span>):4664&#x02013;74. doi: 10.1038/sj.onc.1206619
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1630768/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12879011" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1206619" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Prolactin+induces+ERalpha-positive+and+ERalpha-negative+mammary+cancer+in+transgenic+mice&amp;author=TA+Rose-Hellekant&amp;author=LM+Arendt&amp;author=MD+Schroeder&amp;author=K+Gilchrist&amp;author=EP+Sandgren&amp;volume=22&amp;issue=30&amp;publication_year=2003&amp;doi=10.1038/sj.onc.1206619&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66">66. <span class="mixed-citation">
Courtillot C, Chakhtoura Z, Bogorad R, Genestie C, Bernichtein S, Badachi Y. <span class="ref-title">Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas</span>. <span class="ref-journal">J Clin Endocrinol Metab</span> (2010) <span class="ref-vol">95</span>:271&#x02013;9. doi: 10.1210/jc.2009-1494
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19897676" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fjc.2009-1494" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Characterization+of+two+constitutively+active+prolactin+receptor+variants+in+a+cohort+of+95+women+with+multiple+breast+fibroadenomas&amp;author=C+Courtillot&amp;author=Z+Chakhtoura&amp;author=R+Bogorad&amp;author=C+Genestie&amp;author=S+Bernichtein&amp;volume=95&amp;publication_year=2010&amp;doi=10.1210/jc.2009-1494&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B67">67. <span class="mixed-citation">
Chakhtoura Z, Laki F, Bernadet M, Cherifi I, Chiche A, Pigat N, et al.. <span class="ref-title">Gain-of-function prolactin receptor variants are not associated with breast cancer and multiple fibroadenoma risk</span>. <span class="ref-journal">J Clin Endocrinol Metab</span> (2016) <span class="ref-vol">101</span>(<span class="ref-iss">11</span>):4449&#x02013;60. doi: 10.1210/jc.2016-2372
 [<a href="https://pubmed.ncbi.nlm.nih.gov/27575941" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fjc.2016-2372" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Gain-of-function+prolactin+receptor+variants+are+not+associated+with+breast+cancer+and+multiple+fibroadenoma+risk&amp;author=Z+Chakhtoura&amp;author=F+Laki&amp;author=M+Bernadet&amp;author=I+Cherifi&amp;author=A+Chiche&amp;volume=101&amp;issue=11&amp;publication_year=2016&amp;doi=10.1210/jc.2016-2372&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B68">68. <span class="mixed-citation">
Mong FY, Kuo YL, Liu CW, Liu WS, Chang LC. <span class="ref-title">Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women</span>. <span class="ref-journal">Mol Biol Rep</span> (2011) <span class="ref-vol">38</span>:4629&#x02013;36. doi: 10.1007/s11033-010-0596-y
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21125332" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11033-010-0596-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Rep&amp;title=Association+of+gene+polymorphisms+in+prolactin+and+its+receptor+with+breast+cancer+risk+in+Taiwanese+women&amp;author=FY+Mong&amp;author=YL+Kuo&amp;author=CW+Liu&amp;author=WS+Liu&amp;author=LC+Chang&amp;volume=38&amp;publication_year=2011&amp;doi=10.1007/s11033-010-0596-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B69">69. <span class="mixed-citation">
Acosta JJ, Munoz RM, Gonzalez L, Subtil-Rodriguez A, Dominguez-Caceres MA, Garcia-Martinez JM, et al.. <span class="ref-title">Src mediates prolactin-dependent proliferation of T47D and MCF7 cells <em>via</em> the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways</span>. <span class="ref-journal">Mol Endocrinol</span> (2003) <span class="ref-vol">17</span>:2268&#x02013;82. doi: 10.1210/me.2002-0422
 [<a href="https://pubmed.ncbi.nlm.nih.gov/12907754" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fme.2002-0422" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Src+mediates+prolactin-dependent+proliferation+of+T47D+and+MCF7+cells+via+the+activation+of+focal+adhesion+kinase/Erk1/2+and+phosphatidylinositol+3-kinase+pathways&amp;author=JJ+Acosta&amp;author=RM+Munoz&amp;author=L+Gonzalez&amp;author=A+Subtil-Rodriguez&amp;author=MA+Dominguez-Caceres&amp;volume=17&amp;publication_year=2003&amp;doi=10.1210/me.2002-0422&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B70">70. <span class="mixed-citation">
Kavarthapu R, Tsai Morris CH, Dufau ML. <span class="ref-title">Prolactin induces up-regulation of its cognate receptor in breast cancer cells <em>via</em> transcriptional activation of its generic promoter by cross-talk between ER&#x003b1; and STAT5</span>. <span class="ref-journal">Oncotarget</span> (2014) <span class="ref-vol">5</span>:90 79&#x02013;9091. doi: 10.18632/oncotarget.2376
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4253420/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25193864" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.2376" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Prolactin+induces+up-regulation+of+its+cognate+receptor+in+breast+cancer+cells+via+transcriptional+activation+of+its+generic+promoter+by+cross-talk+between+ER&#x003b1;+and+STAT5&amp;author=R+Kavarthapu&amp;author=CH+Tsai+Morris&amp;author=ML+Dufau&amp;volume=5&amp;publication_year=2014&amp;doi=10.18632/oncotarget.2376&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B71">71. <span class="mixed-citation">
Aksamitiene E, Achanta S, Kolch W, Kholodenko BN, Hoek JB, Kiyatkin A. <span class="ref-title">Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells</span>. <span class="ref-journal">Cell Signal</span> (2011) <span class="ref-vol">23</span>:1794&#x02013;805. doi: 10.1016/j.cellsig.2011.06.014
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3156300/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21726627" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cellsig.2011.06.014" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Signal&amp;title=Prolactin-stimulated+activation+of+ERK1/2+mitogen-activated+protein+kinases+is+controlled+by+PI3-kinase/Rac/PAK+signaling+pathway+in+breast+cancer+cells&amp;author=E+Aksamitiene&amp;author=S+Achanta&amp;author=W+Kolch&amp;author=BN+Kholodenko&amp;author=JB+Hoek&amp;volume=23&amp;publication_year=2011&amp;doi=10.1016/j.cellsig.2011.06.014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B72">72. <span class="mixed-citation">
Tune BXJ, Sim MS, Poh CL, Guad RM, Woon CK, Hazarika I, et al.. <span class="ref-title">Matrix metalloproteinases in chemoresistance: Regulatory roles, molecular interactions, and potential inhibitors</span>. <span class="ref-journal">J Oncol</span> (2022) <span class="ref-vol">2022</span>:3249766. doi: 10.1155/2022/3249766
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9110224/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35586209" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1155%2F2022%2F3249766" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Oncol&amp;title=Matrix+metalloproteinases+in+chemoresistance:+Regulatory+roles,+molecular+interactions,+and+potential+inhibitors&amp;author=BXJ+Tune&amp;author=MS+Sim&amp;author=CL+Poh&amp;author=RM+Guad&amp;author=CK+Woon&amp;volume=2022&amp;publication_year=2022&amp;pages=3249766&amp;pmid=35586209&amp;doi=10.1155/2022/3249766&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B73">73. <span class="mixed-citation">
Barcus CE, et al.. <span class="ref-title">Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells</span>. <span class="ref-journal">J Biol Chem</span> (2013) <span class="ref-vol">288</span>(<span class="ref-iss">18</span>):12722&#x02013;32. doi: 10.1074/jbc.M112.447631
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3642318/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23530035" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M112.447631" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Stiff+collagen+matrices+increase+tumorigenic+prolactin+signaling+in+breast+cancer+cells&amp;author=CE+Barcus&amp;volume=288&amp;issue=18&amp;publication_year=2013&amp;doi=10.1074/jbc.M112.447631&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B74">74. <span class="mixed-citation">
Barcus CE, Keely PJ, Eliceiri KW, Schuler LA. <span class="ref-title">Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells</span>. <span class="ref-journal">Oncotarget</span> (2016) <span class="ref-vol">7</span>:48093&#x02013;106. doi: 10.18632/oncotarget.10137
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5217003/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27344177" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.10137" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Prolactin+signaling+through+focal+adhesion+complexes+is+amplified+by+stiff+extracellular+matrices+in+breast+cancer+cells&amp;author=CE+Barcus&amp;author=PJ+Keely&amp;author=KW+Eliceiri&amp;author=LA+Schuler&amp;volume=7&amp;publication_year=2016&amp;doi=10.18632/oncotarget.10137&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B75">75. <span class="mixed-citation">
Barcus CE, Holt EC, Keely PJ, Eliceiri KW, Schuler LA. <span class="ref-title">Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells</span>. <span class="ref-journal">PloS One</span> (2015) <span class="ref-vol">10</span>(<span class="ref-iss">1</span>):e0116891. doi: 10.1371/journal.pone.0116891
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4301649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25607819" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0116891" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PloS+One&amp;title=Dense+collagen-I+matrices+enhance+pro-tumorigenic+estrogen-prolactin+crosstalk+in+MCF-7+and+T47D+breast+cancer+cells&amp;author=CE+Barcus&amp;author=EC+Holt&amp;author=PJ+Keely&amp;author=KW+Eliceiri&amp;author=LA+Schuler&amp;volume=10&amp;issue=1&amp;publication_year=2015&amp;pages=e0116891&amp;pmid=25607819&amp;doi=10.1371/journal.pone.0116891&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B76">76. <span class="mixed-citation">
Harrington KM, Clevenger CV. <span class="ref-title">Identification of NEK3 kinase threonine 165 as a novel regulatory phosphorylation site that modulates focal adhesion remodeling necessary for breast cancer cell migration</span>. <span class="ref-journal">J Biol Chem</span> (2016) <span class="ref-vol">291</span>(<span class="ref-iss">41</span>):21388&#x02013;406. doi: 10.1074/jbc.M116.726190
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5076809/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27489110" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M116.726190" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+NEK3+kinase+threonine+165+as+a+novel+regulatory+phosphorylation+site+that+modulates+focal+adhesion+remodeling+necessary+for+breast+cancer+cell+migration&amp;author=KM+Harrington&amp;author=CV+Clevenger&amp;volume=291&amp;issue=41&amp;publication_year=2016&amp;doi=10.1074/jbc.M116.726190&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B77">77. <span class="mixed-citation">
Gonz&#x000e1;lez L, Zambrano A, Lazaro-Trueba I, Lop&#x000e9;z E, Gonz&#x000e1;lez JJ, Mart&#x000ed;n-P&#x000e9;rez J, et al.. <span class="ref-title">Activation of the unliganded estrogen receptor by prolactin in breast cancer cells</span>. <span class="ref-journal">Oncogene</span> (2009) <span class="ref-vol">28</span>(<span class="ref-iss">10</span>):1298&#x02013;308. doi: 10.1038/onc.2008.473
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19169277" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fonc.2008.473" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Activation+of+the+unliganded+estrogen+receptor+by+prolactin+in+breast+cancer+cells&amp;author=L+Gonz&#x000e1;lez&amp;author=A+Zambrano&amp;author=I+Lazaro-Trueba&amp;author=E+Lop&#x000e9;z&amp;author=JJ+Gonz&#x000e1;lez&amp;volume=28&amp;issue=10&amp;publication_year=2009&amp;doi=10.1038/onc.2008.473&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B78">78. <span class="mixed-citation">
Oladimeji P, Skerl R, Rusch C, Diakonova M. <span class="ref-title">Synergistic activation of ER&#x003b1; by estrogen and prolactin in breast cancer cells requires tyrosyl phosphorylation of PAK1</span>. <span class="ref-journal">Cancer Res</span> (2016) <span class="ref-vol">76</span>(<span class="ref-iss">9</span>):2600&#x02013;11. doi: 10.1158/0008-5472.CAN-15-1758
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4873454/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26944939" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-15-1758" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Synergistic+activation+of+ER&#x003b1;+by+estrogen+and+prolactin+in+breast+cancer+cells+requires+tyrosyl+phosphorylation+of+PAK1&amp;author=P+Oladimeji&amp;author=R+Skerl&amp;author=C+Rusch&amp;author=M+Diakonova&amp;volume=76&amp;issue=9&amp;publication_year=2016&amp;doi=10.1158/0008-5472.CAN-15-1758&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B79">79. <span class="mixed-citation">
Halim CE, Deng S, Ong MS, Yap CT. <span class="ref-title">Involvement of STAT5 in oncogenesis</span>. <span class="ref-journal">Biomedicines</span> (2020) <span class="ref-vol">8</span>:316. doi: 10.3390/biomedicines8090316
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7555335/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32872372" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fbiomedicines8090316" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Involvement+of+STAT5+in+oncogenesis&amp;author=CE+Halim&amp;author=S+Deng&amp;author=MS+Ong&amp;author=CT+Yap&amp;volume=8&amp;publication_year=2020&amp;pages=316&amp;doi=10.3390/biomedicines8090316&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B80">80. <span class="mixed-citation">
Walker SR, Xiang M, Frank DA. <span class="ref-title">Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer</span>. <span class="ref-journal">Mol Cell Endocrinol</span> (2014) <span class="ref-vol">382</span>(<span class="ref-iss">1</span>):616&#x02013;21. doi: 10.1016/j.mce.2013.03.010
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3732813/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23531638" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mce.2013.03.010" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Endocrinol&amp;title=Distinct+roles+of+STAT3+and+STAT5+in+the+pathogenesis+and+targeted+therapy+of+breast+cancer&amp;author=SR+Walker&amp;author=M+Xiang&amp;author=DA+Frank&amp;volume=382&amp;issue=1&amp;publication_year=2014&amp;doi=10.1016/j.mce.2013.03.010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B81">81. <span class="mixed-citation">
Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, et al.. <span class="ref-title">Signal transducer and activator of transcription-5 activation and breast cancer prognosis</span>. <span class="ref-journal">J Clin Oncol</span> (2004) <span class="ref-vol">22</span>:2053&#x02013;60. doi: 10.1200/JCO.2004.11.046
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15169792" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2004.11.046" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Signal+transducer+and+activator+of+transcription-5+activation+and+breast+cancer+prognosis&amp;author=MT+Nevalainen&amp;author=J+Xie&amp;author=J+Torhorst&amp;author=L+Bubendorf&amp;author=P+Haas&amp;volume=22&amp;publication_year=2004&amp;doi=10.1200/JCO.2004.11.046&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B82">82. <span class="mixed-citation">
Woock AE, Grible JM, Olex AL, Harrell JC, Zot P, Idowu M, et al.. <span class="ref-title">Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer</span>. <span class="ref-journal">Sci Rep</span> (2021) <span class="ref-vol">11</span>(<span class="ref-iss">1</span>):13506. doi: 10.1038/s41598-021-92830-8
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8242097/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34188118" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-021-92830-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Serine+residues+726+and+780+have+nonredundant+roles+regulating+STAT5a+activity+in+luminal+breast+cancer&amp;author=AE+Woock&amp;author=JM+Grible&amp;author=AL+Olex&amp;author=JC+Harrell&amp;author=P+Zot&amp;volume=11&amp;issue=1&amp;publication_year=2021&amp;pages=13506&amp;pmid=34188118&amp;doi=10.1038/s41598-021-92830-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B83">83. <span class="mixed-citation">
Johnson KJ, Peck AR, Liu C, Tran TH, Utama FE, Sjolund AB, et al.. <span class="ref-title">PTP1B suppresses prolactin activation of Stat5 in breast cancer cells</span>. <span class="ref-journal">Am J Pathol</span> (2010) <span class="ref-vol">177</span>(<span class="ref-iss">6</span>):2971&#x02013;83. doi: 10.2353/ajpath.2010.090399
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2993292/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20952588" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2353%2Fajpath.2010.090399" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=PTP1B+suppresses+prolactin+activation+of+Stat5+in+breast+cancer+cells&amp;author=KJ+Johnson&amp;author=AR+Peck&amp;author=C+Liu&amp;author=TH+Tran&amp;author=FE+Utama&amp;volume=177&amp;issue=6&amp;publication_year=2010&amp;doi=10.2353/ajpath.2010.090399&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B84">84. <span class="mixed-citation">
Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. <span class="ref-title">Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells</span>. <span class="ref-journal">Oncogene</span> (2005) <span class="ref-vol">24</span>(<span class="ref-iss">5</span>):746&#x02013;60. doi: 10.1038/sj.onc.1208203
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15592524" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1208203" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Stat5+promotes+homotypic+adhesion+and+inhibits+invasive+characteristics+of+human+breast+cancer+cells&amp;author=AS+Sultan&amp;author=J+Xie&amp;author=MJ+LeBaron&amp;author=EL+Ealley&amp;author=MT+Nevalainen&amp;volume=24&amp;issue=5&amp;publication_year=2005&amp;doi=10.1038/sj.onc.1208203&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B85">85. <span class="mixed-citation">
Kavarthapu R, Dufau ML. <span class="ref-title">Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells</span>. <span class="ref-journal">Oncotarget</span> (2017) <span class="ref-vol">8</span>(<span class="ref-iss">16</span>):27353&#x02013;63. doi: 10.18632/oncotarget.16040
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5432340/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28423697" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.16040" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Essential+role+of+endogenous+prolactin+and+CDK7+in+estrogen-induced+upregulation+of+the+prolactin+receptor+in+breast+cancer+cells&amp;author=R+Kavarthapu&amp;author=ML+Dufau&amp;volume=8&amp;issue=16&amp;publication_year=2017&amp;doi=10.18632/oncotarget.16040&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B86">86. <span class="mixed-citation">
Galbaugh T, Feeney YB, Clevenger CV. <span class="ref-title">Prolactin receptor-integrin cross-talk mediated by SIRP&#x003b1; in breast cancer cells</span>. <span class="ref-journal">Mol Cancer Res</span> (2010) <span class="ref-vol">8</span>(<span class="ref-iss">10</span>):1413&#x02013;24. doi: 10.1158/1541-7786.MCR-10-0130
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2974029/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20826546" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1541-7786.MCR-10-0130" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Res&amp;title=Prolactin+receptor-integrin+cross-talk+mediated+by+SIRP&#x003b1;+in+breast+cancer+cells&amp;author=T+Galbaugh&amp;author=YB+Feeney&amp;author=CV+Clevenger&amp;volume=8&amp;issue=10&amp;publication_year=2010&amp;doi=10.1158/1541-7786.MCR-10-0130&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B87">87. <span class="mixed-citation">
Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW, et al.. <span class="ref-title">Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells</span>. <span class="ref-journal">Endocrine-Related Cancer</span> (2010) <span class="ref-vol">17</span>:809&#x02013;22. doi: 10.1677/ERC-09-0326
 [<a href="https://pubmed.ncbi.nlm.nih.gov/20601496" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1677%2FERC-09-0326" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine-Related+Cancer&amp;title=Prolactin+and+oestrogen+synergistically+regulate+gene+expression+and+proliferation+of+breast+cancer+cells&amp;author=LM+Rasmussen&amp;author=KS+Frederiksen&amp;author=N+Din&amp;author=E+Galsgaard&amp;author=L+Christensen&amp;volume=17&amp;publication_year=2010&amp;doi=10.1677/ERC-09-0326&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B88">88. <span class="mixed-citation">
Gutzman JH, Nikolai SE, Rugowski DE, Watters JJ, Schuler LA. <span class="ref-title">Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos</span>. <span class="ref-journal">Mol Endocrinol</span> (2005) <span class="ref-vol">19</span>(<span class="ref-iss">7</span>):1765&#x02013;78. doi: 10.1210/me.2004-0339
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1630766/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15746191" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1210%2Fme.2004-0339" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Prolactin+and+estrogen+enhance+the+activity+of+activating+protein+1+in+breast+cancer+cells:+role+of+extracellularly+regulated+kinase+1/2-mediated+signals+to+c-fos&amp;author=JH+Gutzman&amp;author=SE+Nikolai&amp;author=DE+Rugowski&amp;author=JJ+Watters&amp;author=LA+Schuler&amp;volume=19&amp;issue=7&amp;publication_year=2005&amp;doi=10.1210/me.2004-0339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B89">89. <span class="mixed-citation">
Leehy KA, Truong TH, Mauro LJ, Lange CA. <span class="ref-title">Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models</span>. <span class="ref-journal">J Steroid Biochem Mol Biol</span> (2018) <span class="ref-vol">176</span>:88&#x02013;93. doi: 10.1016/j.jsbmb.2017.04.011
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5653461/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28442393" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jsbmb.2017.04.011" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Steroid+Biochem+Mol+Biol&amp;title=Progesterone+receptors+(PR)+mediate+STAT+actions:+PR+and+prolactin+receptor+signaling+crosstalk+in+breast+cancer+models&amp;author=KA+Leehy&amp;author=TH+Truong&amp;author=LJ+Mauro&amp;author=CA+Lange&amp;volume=176&amp;publication_year=2018&amp;pages=88-93&amp;pmid=28442393&amp;doi=10.1016/j.jsbmb.2017.04.011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B90">90. <span class="mixed-citation">
Hagan CR, Daniel AR, Dressing GE, Lange CA. <span class="ref-title">Role of phosphorylation in progesterone receptor signaling and specificity</span>. <span class="ref-journal">Mol Cell Endocrinol</span> (2012) <span class="ref-vol">357</span>:43&#x02013;9. doi: 10.1016/j.mce.2011.09.017
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3265648/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21945472" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mce.2011.09.017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Endocrinol&amp;title=Role+of+phosphorylation+in+progesterone+receptor+signaling+and+specificity&amp;author=CR+Hagan&amp;author=AR+Daniel&amp;author=GE+Dressing&amp;author=CA+Lange&amp;volume=357&amp;publication_year=2012&amp;doi=10.1016/j.mce.2011.09.017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B91">91. <span class="mixed-citation">
Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, et al.. <span class="ref-title">Endocrine therapy for hormone receptor-positive metastatic breast cancer: American society of clinical oncology guideline</span>. <span class="ref-journal">J Clin Oncol</span> (2016) <span class="ref-vol">34</span>:3069&#x02013;103. doi: 10.1200/JCO.2016.67.1487
 [<a href="https://pubmed.ncbi.nlm.nih.gov/27217461" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2016.67.1487" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Endocrine+therapy+for+hormone+receptor-positive+metastatic+breast+cancer:+American+society+of+clinical+oncology+guideline&amp;author=HS+Rugo&amp;author=RB+Rumble&amp;author=E+Macrae&amp;author=DL+Barton&amp;author=HK+Connolly&amp;volume=34&amp;publication_year=2016&amp;doi=10.1200/JCO.2016.67.1487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B92">92. <span class="mixed-citation">
Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al.. <span class="ref-title">Breast cancer</span>. <span class="ref-journal">Nat Rev Dis Primers</span> (2019) <span class="ref-vol">5</span>(<span class="ref-iss">1</span>):66. doi: 10.1038/s41572-019-0111-2
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31548545" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41572-019-0111-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Dis+Primers&amp;title=Breast+cancer&amp;author=N+Harbeck&amp;author=F+Penault-Llorca&amp;author=J+Cortes&amp;author=M+Gnant&amp;author=N+Houssami&amp;volume=5&amp;issue=1&amp;publication_year=2019&amp;pages=66&amp;pmid=31548545&amp;doi=10.1038/s41572-019-0111-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B93">93. <span class="mixed-citation">
Osborne CK, Schiff R. <span class="ref-title">Mechanisms of endocrine resistance in breast cancer</span>. <span class="ref-journal">Annu Rev Med</span> (2011) <span class="ref-vol">62</span>(<span class="ref-iss">1</span>):233&#x02013;47. doi: 10.1146/annurev-med-070909-182917
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3656649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20887199" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev-med-070909-182917" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med&amp;title=Mechanisms+of+endocrine+resistance+in+breast+cancer&amp;author=CK+Osborne&amp;author=R+Schiff&amp;volume=62&amp;issue=1&amp;publication_year=2011&amp;doi=10.1146/annurev-med-070909-182917&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B94">94. <span class="mixed-citation">
Murphy CG, Dickler MN. <span class="ref-title">Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies</span>. <span class="ref-journal">Endocr Relat Cancer</span> (2016) <span class="ref-vol">23</span>(<span class="ref-iss">8</span>):R337&#x02013;52. doi: 10.1530/ERC-16-0121
 [<a href="https://pubmed.ncbi.nlm.nih.gov/27406875" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1530%2FERC-16-0121" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Relat+Cancer&amp;title=Endocrine+resistance+in+hormone-responsive+breast+cancer:+mechanisms+and+therapeutic+strategies&amp;author=CG+Murphy&amp;author=MN+Dickler&amp;volume=23&amp;issue=8&amp;publication_year=2016&amp;doi=10.1530/ERC-16-0121&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B95">95. <span class="mixed-citation">
Rani A, Stebbing J, Giamas G, Murphy J. <span class="ref-title">Endocrine resistance in hormone receptor positive breast cancer-from mechanism to therapy</span>. <span class="ref-journal">Front Endocrinol</span> (2019) <span class="ref-vol">10</span>:245. doi: 10.3389/fendo.2019.00245
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6543000/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31178825" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffendo.2019.00245" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Endocrinol&amp;title=Endocrine+resistance+in+hormone+receptor+positive+breast+cancer-from+mechanism+to+therapy&amp;author=A+Rani&amp;author=J+Stebbing&amp;author=G+Giamas&amp;author=J+Murphy&amp;volume=10&amp;publication_year=2019&amp;pages=245&amp;doi=10.3389/fendo.2019.00245&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B96">96. <span class="mixed-citation">
Kavarthapu R, Dufau ML. <span class="ref-title">Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells</span>. <span class="ref-journal">Oncotarget</span> (2016) <span class="ref-vol">7</span>(<span class="ref-iss">40</span>):65602&#x02013;13. doi: 10.18632/oncotarget.11579
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5323178/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27564112" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.11579" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Role+of+EGF/ERBB1+in+the+transcriptional+regulation+of+the+prolactin+receptor+independent+of+estrogen+and+prolactin+in+breast+cancer+cells&amp;author=R+Kavarthapu&amp;author=ML+Dufau&amp;volume=7&amp;issue=40&amp;publication_year=2016&amp;doi=10.18632/oncotarget.11579&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B97">97. <span class="mixed-citation">
Nahta R. <span class="ref-title">Molecular mechanisms of trastuzumab-based treatment in HER2-overexpressing breast cancer</span>. <span class="ref-journal">ISRN Oncol</span> (2012) <span class="ref-vol">2012</span>:428062. doi: 10.5402/2012/428062
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3512309/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23227361" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5402%2F2012%2F428062" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ISRN+Oncol&amp;title=Molecular+mechanisms+of+trastuzumab-based+treatment+in+HER2-overexpressing+breast+cancer&amp;author=R+Nahta&amp;volume=2012&amp;publication_year=2012&amp;pages=428062&amp;pmid=23227361&amp;doi=10.5402/2012/428062&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B98">98. <span class="mixed-citation">
Orphanos G, Kountourakis P. <span class="ref-title">Targeting the HER2 receptor in metastatic breast cancer</span>. <span class="ref-journal">Hematol Oncol Stem Cell Ther</span> (2012) <span class="ref-vol">5</span>:127&#x02013;37. doi: 10.5144/1658-3876.2012.127
 [<a href="https://pubmed.ncbi.nlm.nih.gov/23095788" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5144%2F1658-3876.2012.127" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hematol+Oncol+Stem+Cell+Ther&amp;title=Targeting+the+HER2+receptor+in+metastatic+breast+cancer&amp;author=G+Orphanos&amp;author=P+Kountourakis&amp;volume=5&amp;publication_year=2012&amp;doi=10.5144/1658-3876.2012.127&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B99">99. <span class="mixed-citation">
Schlam I, Swain SM. <span class="ref-title">HER2-positive breast cancer and tyrosine kinase inhibitors: The time is now</span>. <span class="ref-journal">NPJ Breast Cancer</span> (2021) <span class="ref-vol">7</span>:56. doi: 10.1038/s41523-021-00265-1
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8137941/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34016991" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41523-021-00265-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=NPJ+Breast+Cancer&amp;title=HER2-positive+breast+cancer+and+tyrosine+kinase+inhibitors:+The+time+is+now&amp;author=I+Schlam&amp;author=SM+Swain&amp;volume=7&amp;publication_year=2021&amp;pages=56&amp;pmid=34016991&amp;doi=10.1038/s41523-021-00265-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B100">100. <span class="mixed-citation">
Zanardi E, Bregni G, de Braud F, Di Cosimo S. <span class="ref-title">Better together: Targeted combination therapies in breast cancer</span>. <span class="ref-journal">Semin Oncol</span> (2015) <span class="ref-vol">42</span>(<span class="ref-iss">6</span>):887&#x02013;95. doi: 10.1053/j.seminoncol.2015.09.029
 [<a href="https://pubmed.ncbi.nlm.nih.gov/26615133" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fj.seminoncol.2015.09.029" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Oncol&amp;title=Better+together:+Targeted+combination+therapies+in+breast+cancer&amp;author=E+Zanardi&amp;author=G+Bregni&amp;author=F+de+Braud&amp;author=S+Di+Cosimo&amp;volume=42&amp;issue=6&amp;publication_year=2015&amp;doi=10.1053/j.seminoncol.2015.09.029&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B101">101. <span class="mixed-citation">
Minami H, Ando Y, Tamura K, Tajima T, Isaacs R. <span class="ref-title">Phase I study of LFA102 in patients with advanced breast cancer or castration-resistant prostate cancer</span>. <span class="ref-journal">Anticancer Res</span> (2020) <span class="ref-vol">40</span>(<span class="ref-iss">9</span>):5229&#x02013;35. doi: 10.21873/anticanres.14526
 [<a href="https://pubmed.ncbi.nlm.nih.gov/32878811" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.21873%2Fanticanres.14526" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res&amp;title=Phase+I+study+of+LFA102+in+patients+with+advanced+breast+cancer+or+castration-resistant+prostate+cancer&amp;author=H+Minami&amp;author=Y+Ando&amp;author=K+Tamura&amp;author=T+Tajima&amp;author=R+Isaacs&amp;volume=40&amp;issue=9&amp;publication_year=2020&amp;doi=10.21873/anticanres.14526&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B102">102. <span class="mixed-citation">
Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY. <span class="ref-title">Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells</span>. <span class="ref-journal">Breast Cancer Res Treat</span> (2008) <span class="ref-vol">111</span>(<span class="ref-iss">2</span>):241&#x02013;50. doi: 10.1007/s10549-007-9789-z
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17955362" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10549-007-9789-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Additive+effects+of+a+prolactin+receptor+antagonist,+G129R,+and+herceptin+on+inhibition+of+HER2-overexpressing+breast+cancer+cells&amp;author=ML+Scotti&amp;author=JF+Langenheim&amp;author=S+Tomblyn&amp;author=AE+Springs&amp;author=WY+Chen&amp;volume=111&amp;issue=2&amp;publication_year=2008&amp;doi=10.1007/s10549-007-9789-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B103">103. <span class="mixed-citation">
Paplomata E, O'Regan R. <span class="ref-title">The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers</span>. <span class="ref-journal">Ther Adv Med Oncol</span> (2014) <span class="ref-vol">6</span>(<span class="ref-iss">4</span>):154&#x02013;66. doi: 10.1177/1758834014530023
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4107712/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25057302" ref="reftype=pubmed&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F1758834014530023" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ther+Adv+Med+Oncol&amp;title=The+PI3K/AKT/mTOR+pathway+in+breast+cancer:+Targets,+trials+and+biomarkers&amp;author=E+Paplomata&amp;author=R+O'Regan&amp;volume=6&amp;issue=4&amp;publication_year=2014&amp;doi=10.1177/1758834014530023&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9520000&amp;issue-id=400438&amp;journal-id=1753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Frontiers in Endocrinology</span> are provided here courtesy of <strong>Frontiers Media SA</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9520000/pdf/fendo-13-949396.pdf" class="int-view">PDF (1.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9520000/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9520000/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9520000" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="6SnIDP8P2pvVL79iobxd4RuD5u5rYHGSXZxJFfIgVqXtfA966NZjhoOM5VeQuNMC">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F&amp;text=Prolactin%20receptor%20gene%20transcriptional%20control%2C%20regulatory%20modalities%20relevant%20to%20breast%20cancer%20resistance%20and%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9520000%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520000/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36187116/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36187116/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9520000/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9520000/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC9520000/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
